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Abstract
Poxviruses have evolved multiple strategies to subvert signaling by Nuclear Factor κB (NF-κB),
a crucial regulator of host innate immune responses. Here, we describe an orf virus (ORFV)
virion-associated protein, ORFV119, which inhibits NF-κB signaling very early in infection ( 30
min post infection). ORFV119 NF-κB inhibitory activity was found unimpaired upon translation
inhibition, suggesting that virion ORFV119 alone is responsible for early interference in signaling.
A C-terminal LxCxE motif in ORFV119 enabled the protein to interact with the retinoblastoma
protein (pRb) a multifunctional protein best known for its tumor suppressor activity. Notably,
experiments using a recombinant virus containing an ORFV119 mutation which abrogates its
interaction with pRb together with experiments performed in cells lacking or with reduced pRb
levels indicate that ORFV119 mediated inhibition of NF-κB signaling is largely pRb dependent.
ORFV119 was shown to inhibit IKK complex activation early in infection. Consistent with IKK
inhibition, ORFV119 also interacted with TNF receptor associated factor 2 (TRAF2), an adaptor
protein recruited to signaling complexes upstream of IKK in infected cells. ORFV119-TRAF2
interaction was enhanced in the presence of pRb, suggesting that ORFV119-pRb complex is
required for efficient interaction with TRAF2. Additionally, transient expression of ORFV119 in
uninfected cells was sufficient to inhibit TNFα-induced IKK activation and NF-κB signaling, indi-
cating that no other viral proteins are required for the effect. Infection of sheep with ORFV lacking
the ORFV119 gene led to attenuated disease phenotype, indicating that ORFV119 contributes
to virulence in the natural host. ORFV119 represents the first poxviral protein to interfere with
NF-κB signaling through interaction with pRb.
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Author summary
Poxviruses have evolved multiple strategies to subvert signaling by NF-κB, a crucial regu-
lator of host innate immune responses. Viruses often encode multiple inhibitory proteins,
which largely target cytoplasmic activation events of NF-κB signaling. The retinoblastoma
protein (pRb), a multifunctional protein best known for its tumor suppressor activity, has
been suggested to affect NF-κB signaling during virus infection however, viral effectors
and mechanisms of actions are unknown. Here, we identified a virion-associated orf virus
NF-κB inhibitory protein, ORFV119, which interacts with pRb. ORFV119 was shown to
inhibit IKK complex activation in a pRb-dependent manner early in infection. Results
show that ORFV119 interacted with both pRb and TRAF2 and that a ORFV119-pRb com-
plex likely is required for efficient interaction with TRAF2 and inhibition of NF-κB signal-
ing. ORFV119 represents the first poxviral protein to interfere with NF-κB signaling
through interaction with pRb.
Introduction
Orf virus (ORFV), the type member of the genus Parapoxvirus of the Poxviridae, is the causa-
tive agent of orf or contagious ecthyma, a ubiquitous disease of sheep and goats characterized
by proliferative lesions affecting muco-cutaneous tissues of the mouth and muzzle [1,2]. Orf is
a zoonotic disease affecting humans in close contact with infected animals [3–5].
Like other parapoxviruses (PPV), ORFV is highly epitheliotropic, and keratinocytes and
their ontogenetically related counterparts in the oral mucosa are the most important if not the
only cell type to support ORFV replication in vivo [6]. In addition to producing the essential
protective stratum corneum of the epidermis, keratinocytes function as immune sentinels and
instigators of inflammatory responses in the skin, representing a specialized branch of the
innate immune system. Keratinocytes are well equipped for pathogen sensing as they express a
broad spectrum of pattern recognition receptors (PRRs), including surface and endosomal toll-
like receptors (TLRs), NOD-like receptors (NLRs), and retinoic acid-inducible gene (RIG-I)-
like receptors, and rapidly respond to cell injury and infection by releasing critical pro-inflam-
matory chemokines and cytokines such as tumor necrosis factor α (TNFα) and interleukin 1
(IL-1) [7,8]. Engagement of these receptors initiates downstream pro-inflammatory cascades,
including the NF-κB signaling pathway, which mediates innate immune responses and contrib-
utes to skin homeostasis by regulating keratinocyte proliferation and differentiation [9].
The NF-κB family of transcription factors consists of five members, NF-κB-p65 (RelA),
RelB, c-Rel, NF-κB-p50/p105, and NF-κB-p52/p100, which contain an N-terminal Rel homol-
ogy domain (RHD) responsible for homo- and heterodimerization and for sequence specific
DNA binding [10]. In unstimulated cells, NF-κB dimers are sequestered in the cytoplasm
through binding to the inhibitor kappa-B alpha (IκBα). Following cell stimulation, IKK com-
plex-mediated phosphorylation of IκBα results in proteasomal degradation of IκB and nuclear
translocation of p65/p50 dimers, which bind κB-responsive DNA elements, interact with tran-
scription co-regulators, and activate or repress gene expression [11,12]. The critical IKK com-
plex consists of two kinases, IKKα and IKKβ, and the regulatory subunit IKKγ/NF-κB essential
modulator (NEMO) [13,14]. Various stimuli, including those initiated by proinflammatory
cytokines TNFα and IL-1, lead to IKK activation. Engagement of the TNF receptor 1 (TNF-R1)
results in sequential recruitment of TRADD (TNF-R1-associated death domain), TRAF2 (TNF
receptor-associated factor 2) and RIP1 (Receptor-interacting protein 1) [15]. Multiple ubiquiti-
nation events on RIP1 and NEMO bring the TAK1 (TGF-β activated kinase 1) complex close to
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the IKK complex. TAK1-mediated IKKβ phosphorylation and IKKβ auto-phosphorylation acti-
vate IKKβ, which then phosphorylates IκBα [16]. Engagement of the IL-1 receptor, on the other
hand, results in recruitment of IRAK1 (IL-1 receptor–associated kinase) and activation of
TRAF6 (TNF receptor-associated factor 6), which then ubiquitinates and activates TAK1 result-
ing in IKK activation [17,18].
Many viruses with dissimilar life styles are known to interfere with the NF-κB pathway. In
particular, poxviruses have evolved multiple strategies to counteract NF-κB function, indicat-
ing that inhibition of NF-κB-mediated transcription is important for successful infection of
the host. This is not surprising as poxvirus infections are sensed by NF-κB-activating PRRs
such as endosomal TLRs, RIG-I-like receptors, and the inflammasome [19]. General features
of poxviral NF-κB inhibitors include, 1- individual viruses encode for multiple inhibitors, with
vaccinia virus (VACV) encoding at least twelve [20]. While orthologs of some NF-κB inhibi-
tors are found in viruses belonging to multiple poxvirus genera (e.g. VACV A52R, VACV
E3L), others are restricted to a particular genus (e.g. VACV A46R and VACV B14R in Ortho-
poxvirus) or even selected viruses within a genus (PPV ORFV002) [21–29]; 2- in contrast to
other classes of poxviral immunomodulators, poxviral NF-κB inhibitors have no or little
resemblance to host proteins; 3- although inhibitors target extracellular, membrane, cytosolic,
or nuclear events of NF-κB regulation, most inhibitors directly target NF-κB subunits or the
proximal IKKs; 4- despite the multiplicity of inhibitors, there seems to be low or no redun-
dancy as judged by the effect of individual gene deletions on viral pathogenesis; 5- with a few
exceptions (myxoma virus MYXV150, cowpoxvirus CPXV006) no single gene-deletion ren-
dered complete virus attenuation [30–34]; 6- most inhibitors are expressed early after virus
entry into cells.
Apart from VACV E3L (ORFV020), PPV lack homologues of poxviral NF-κB inhibitors
present in other poxviral genera, suggesting that PPV have evolved novel mechanisms to coun-
teract the NF-κB signaling pathway. Recently, we have described four NF-κB inhibitors
encoded by ORFV, ORFV024, ORFV002, ORFV121 and ORFV073 [35–38]. ORFV024 was
shown to inhibit phosphorylation of IKK kinases, thus preventing activation of IKK complex.
ORFV121, a virulence determinant, was shown to bind to- and inhibit phosphorylation and
nuclear translocation of NF-κB-p65 [37]. ORFV002 binds NF-κB-p65 and reduces its acetyla-
tion by co-activator p300 thus inhibiting transactivation [36]. Decreased NF-κB-p65 acetyla-
tion is a consequence of ORFV002 interfering with NF-κB-p65 phosphorylation by mitogen-
and stress-activated protein kinase 1 (MSK1) [39]. ORFV073 inhibits NF-κB signaling by pre-
venting activation of IKK complex through interaction with NEMO, the regulatory subunit of
the IKK complex [38].
The retinoblastoma tumor suppressor, pRb, is a multifunctional, predominantly nuclear
protein encoded by the RB1 gene. pRb affects cell cycle, differentiation and metabolism,
genome stability and apoptosis, mostly but not exclusively through transcription regulation
[40]. Central to pRb function is its ability to nucleate complexes containing multiple interact-
ing partners, thus participating in various regulatory circuits. Viruses have evolved functions
to modulate those pathways by targeting pRb to their advantage. For example, adenovirus
(Ad) protein E1A interaction with pRb and other factors represses select host genes to promote
productive virus infection [41]. The human cytomegalovirus pp71 tegument protein and the
human papillomavirus E7 oncoprotein bind to pRb and induce its degradation thus driving
cells to a cell cycle stage that potentially favors efficient replication of viral genomes [42,43].
pRb has been shown to affect the regulation of the NF-κB pathway following TNFα signaling
or vesicular stomatitis virus infection, although mechanisms involved are not yet defined
[44,45]. Many viral and cellular pRb-interacting proteins contain the motif LxCxE (where x
means any amino acid) that binds to the LxCxE cleft of the pRb pocket domain [46]. Select
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pRb-binding proteins that interact through LxCxE with pRb also bind p107 and p130, the
other two members of the retinoblastoma family of proteins.
Here we show that ORFV119, a LxCxE motif-containing virion protein unique to PPV,




Primary ovine fetal turbinate (OFTu) cells were obtained from Howard D. Lehmkuhl (USDA)
and were maintained in minimal essential medium (MEM) supplemented with 10% fetal
bovine serum (FBS) (Atlanta Biologicals, Flowery Branch, GA), 2 mM L-glutamine, gentami-
cin (50 μg/ml), penicillin (100 IU/ml), and streptomycin (100 μg/ml). Human osteosarcoma
cells (Saos-2, provided by Timothy M. Fan, UIUC), Human embryonic kidney (HEK 293T)
and cervical cancer (HeLa) cells (obtained from American Type Culture Collection), were cul-
tured in Dulbecco’s modified essential medium (DMEM) supplemented as above. Cells were
incubated at 37˚C with 5% CO2. ORFV strain OV-IA82 [47] was used as a parental virus to
construct ORFV119 gene deletion virus OV-IA82-Δ119 and for experiments involving wild
type virus infection. OV-IA82-Δ119 was used as parental virus to construct revertant virus
OV-IA82-RV119Flag, and OV-IA82-RV119LxGxE-Flag, a revertant virus carrying a CxG substitu-
tion in ORFV119 LxCxE motif.
pRb knockdown in OFTu cells (OFTuRb-)
To knockdown pRb expression in OFTu cells, siRNA directed against ovine RB1 was used. A
pool of three RB1 sense (S) and anti-sense (AS) siRNA with following sequences 1-RB1-(S):
CTACCTATAGCAGAAGTAT, RB1-(AS): ATACTTCTGCTATAGGTAG; 2-RB1-(S):
GCTTATATATTTGACACAA, RB1-(AS): TTGTGTCAAATATATAAGC; 3-RB1-(S):
CTCAGATTCACCTTTATTT, RB1-(AS): AAATAAAGGTGAATCTGAG (Custom Oligos:
Sigma Aldrich) were used. Pooled RB1 siRNA (15 nM of each siRNA) were transfected in
OFTu cells (30,000–70,000/well) using MISSION transfection reagent (Sigma Aldrich, Cat #
S1452) following the manufactures’ protocol. At 48 h post transfection, pRb knockdown was
examined by SDS-PAGE, using antibody against pRb (abcam, Cat # ab85607). One MISSION
siRNA Universal Negative Control (SIC001, sigma aldrich) was included in all experiments.
To obtain OV-IA82Rb- or OV-IA82-RV119LxGxE-Flag-Rb- virus stocks (OV-IA82 and OV-
IA82-RV119LxGxE-Flag viruses propagated in cells with reduced pRb levels, respectively), OFTu cells
with reduced pRb levels (OFTuRb- cells) were infected with OV-IA82 or OV-IA82-RV119LxGxE-Flag
virus and supernatants from infected cultures were collected at 24 h p.i and used for NF-κB-p65
nuclear translocation assays.
Plasmids
To construct expression plasmids pORFV119Flag and pORFV119LxGxE-Flag, the ORFV119 or
ORFV119LxGxE coding sequences were PCR-amplified from the OV-IA82 genome and a plas-
mid containing synthetic ORFV119LxGxE sequence (Genscript), respectively with primers 119-
3xFlag-FW (EcoRI): 5’-TAAGGCCTCTGAATTCAATGGACTCTCGTAGGCTC GCTCTT-
3’; 119-3xFlag-RV (BamHI): 5’-CAGAATACGTGGATCCTCAATCGCTGTCG CTGTCG
CCGAG-3’ and cloned into p3xFlag-CMV-10 vector (pFlag) (Clontech, Mountain View, CA).
Similarly, to obtain a ORFV119-green fluorescence protein (ORFV119GFP) expression vector,
ORFV119 sequence was PCR amplified from OV-IA82 genome with primers 119-GFP-FW
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(EcoRI): 5’- TAAGGCCTCTGAATTCATGGACTCTCGTAGGCTCGCTCTT-3’ and 119-
GFP-RV (BamHI): 5’- CAGAATACGTGGATCCAGATCGCTGTCGCTGTCGCCGA GC
G-3’, and cloned into the vector pEGFP-N1 (Clontech, Mountain View, CA). DNA sequencing
of plasmids confirmed the identity and integrity of the constructs.
Construction of ORFV119 gene deletion mutant and revertant viruses
To generate gene deletion mutant virus OV-IA82-Δ119, a recombination cassette (pΔ119-
RFP) containing Vaccinia virus 7.5 promoter (VV7.5)-driven Red Fluorescent Protein (RFP)
gene flanked by 528 bp sequences representing ORFV119 left and right flanking regions was
synthesized and cloned in pUC57 vector (Genscript, Piscataway, NJ). Similarly, to generate
revertant viruses OV-IA82-RV119Flag and OV-IA82-RV119LxGxE-Flag, recombination cassettes
pRV119Flag-GFP and pRV119LxGxE-Flag-GFP were synthesized containing N-terminally tagged
ORFV119 or ORFV119LxGxE sequences, respectively, and a GFP reporter gene, all flanked by
approximately 600 bp of homologous sequence on either side to mediate recombination (Gen-
script, Piscataway, NJ).
To obtain OV-IA82-Δ119, OFTu cells were infected with OV-IA82 (MOI, 1) and trans-
fected with recombination plasmid pΔ119-RFP. To obtain OV-IA82-RV119Flag and OV-
IA82-RV119LxGxE-Flag, OFTu cells were infected with OV-IA82-Δ119 (MOI, 1) and transfected
with recombination plasmids pRV119Flag-GFP or pRV119LxGxE-Flag-GFP. Recombinant viruses
were isolated by limiting dilution and plaque assay using fluorescence microscopy as previ-
ously described [36]. Identity and integrity of DNA sequences in purified viruses was con-
firmed by PCR and DNA sequencing.
Virus purification and virion protein characterization
Semi-purified viruses were used in infection experiments. OFTu cells infected with OV-IA82,
OV-IA82-RV119Flag, OV-IA82-Δ119, or OV-IA82-RV119LxGxE-Flag (MOI, 0.1) were disrupted
by three cycles of freeze and thaw at three days p.i. Cellular debris were removed by centrifuga-
tion at 1500 rpm for 5 min, and supernatants pelleted by ultracentrifugation at 25,000 rpm for
1 h. Pellets were resuspended in MEM and aliquots frozen at -80˚C. Viral titers were obtained
by the Spearman-Karber’s 50% tissue culture infectious dose (TCID50) method.
Extracellular enveloped virus (EEV) and intracellular mature virus (IMV) were purified
using double sucrose gradient purification protocol with modifications [48]. OFTu cells
infected with OV-IA82, OV-IA82-Δ119, OV-IA82-RV119LxGxE-Flag or OV-IA82-RV119Flag
(MOI, 0.1) were harvested at three days p.i. and supernatant (EEV) and cellular (IMV) frac-
tions collected following centrifugation at 1,500 rpm for 5 min. Virus in supernatants was pel-
leted by ultra-centrifugation (25,000 rpm for 1 h), while cellular fractions were disrupted by
three cycles of freeze and thaw and centrifuged to remove cell debris. Further purification
steps were identical for EEV and IMV. Both preparations were sonicated, pelleted through a
36% sucrose cushion, and purified using double sucrose gradient centrifugation. Virus-con-
taining bands were collected, and virus was recovered by centrifugation and resuspended in 10
mM TrisHcl. Whole cell extracts (60 μg) from OV-IA82-RV119Flag infected OFTu cells, and
purified EEV and IMV virion proteins (10 μg) were resolved by SDS-PAGE, blotted to nitro-
cellulose membranes and probed with primary antibodies against Flag (Genscript, Cat #
A00187), ORFV structural protein ORFV086 or Glyceraldehyde-3-Phosphate Dehydrogenase
(GAPDH) (sc-25778; Santa Cruz) overnight at 4˚C [49]. Blots were incubated with appropriate
HRP-labeled secondary antibodies (1:15,000) (anti-mouse, sc-2031 and anti-rabbit, sc-2004;
Santa Cruz) for 1 h at room temperature (RT) and membranes were developed using chemilu-
minescent reagents (SuperSignal West Femto, Thermo Fischer Scientific).
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To examine the effect of protein synthesis inhibitor cycloheximide (CHX) on expression of
ORFV119 and control cellular protein p53. OFTu cells mock treated or treated with CHX
(50 μg/ml) (Sigma-Aldrich, St. Louis, MO) for 30 min were infected with OV-IA82RV119Flag
in presence or absence of CHX and harvested at 30 min, 1 h, 1.5 h and 2 h p.i. Total protein
extracts (50 μg) were resolved by SDS-PAGE, blotted and transferred to nitrocellulose mem-
branes, probed with antibody against Flag, p53 (sc-6243; Santa Cruz) and GAPDH (sc-25778;
Santa Cruz) as described above.
ORFV119 protein expression and subcellular localization
To evaluate ORFV119 expression, OFTu cells were infected with OV-IA82 or OV-IA82-
RV119Flag (MOI, 10) for 2 h, 4 h, 6 h, 8 h, 12 h or 24 h p.i. Total protein extracts (50 μg)
were resolved by SDS-PAGE, blotted and transferred to nitrocellulose membranes, and
probed with primary antibody against Flag and GAPDH. Blots were then incubated with
appropriate HRP-labeled secondary antibodies and developed using chemiluminescent
reagents.
To assess the subcellular localization of ORFV119, OFTu cells (1.5 x 105 cells/well) were cul-
tured in four-well chamber slides (ibidi, Martinsried, Germany) for 16 h and mock infected or
infected with OV-IA82-Δ119 or OV-IA82-RV119Flag (MOI, 10). Cells were fixed at 3 h, 6 h, 12
h, 16 h or 24 h p.i with 4% formaldehyde for 20 min, permeabilized with 0.2% Triton X 100 for
10 min, blocked with 1% bovine serum albumin (Sigma-Aldrich, St. Louis, MO) for 1 h, and
incubated with primary antibody against Flag (Cat # A00187-200; Genscript) overnight at 4˚C.
Cells were then stained with Alexa fluor 594 labelled secondary antibody (Thermo Fisher Sci-
entific, Cat # A-11005), counterstained with DAPI (2 μg/ml) for 10 min and visualized by con-
focal microscopy (A1, Nikon).
Growth curves
To assess the effect of ORFV119 in virus replication, one-step growth curves were determined
in OFTu cells infected with OV-IA82, OV-IA82-Δ119 or OV-IA82-RV119Flag (MOI, 10).
Virus yields were quantitated at 6 h, 12 h, 24 h, 36 h, and 48 h p.i. as described above.
Real-time PCR
To investigate the effect of OV-IA82-Δ119 infection on expression of NF-κB regulated genes,
OFTu cells were mock infected or infected with OV-IA82, OV-IA82-Δ119 or OV-IA82-
RV119Flag (MOI, 10) and harvested at 2 h p.i. RNA was extracted using RNeasy Mini Kit (QIA-
GEN, Cat # 74104) and reverse transcribed as previously described [35]. mRNA for select NF-
κB regulated genes was quantified using ABI Real time PCR system (Applied Biosystems, Fos-
ter city, CA), Power SYBR Green PCR Master Mix (Cat # 4368708, Applied Bio) and the fol-
lowing primers, TNFα (Fwd: 5’-CCTTCAACAGGCCTCTGGTT-3’; Rev: 5’-GTGGGCTAC
CGGCTTGTTAT-3’) IL1β (Fwd 5’-AAATCCCTGGTGCTGG ATAG-3’; Rev: 5’-GTTGTC
TCTTTCCTCTCCTTGT-3’) NF-κB1 (Fwd: 5’- CAGAGAGGA TTTCGTTTCCGT-3’; Rev:
5’-TGCAGATTTTGACCTGAGGGT-3’) IL36α (Fwd: 5’-ATGTCTTCACACCTTGGCAGT-
3’; Rev: 5’-ATCGGGTGTACCCTGGATAA-3’) TLR2 (Fwd: 5’-TTGCTCCTGTGACTTC
CTGTC-3’; Rev: 5’- GAGCGTCACAGCGGTAGC-3’). Data analysis was performed as previ-
ously described [35]. Experiments were conducted with biological triplicates and at least three
technical replicates. Statistical analysis was performed by using Student’s t test.
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NF-κB-p65 nuclear translocation assay
The effect of ORFV119 in TNFα-induced activation of NF-κB was assessed by NF-κB-p65
nuclear translocation assay. HeLa cells transfected with control plasmid (pEGFP-N1) or a plas-
mid encoding ORFV119-GFP fusion protein (pORFV119GFP) were treated with TNFα (20ng/
ml) at 12 h post transfection for 30 min, fixed, permeabilized and blocked as described above,
incubated with primary antibody against NF-κB-p65 (Cell Signaling, Cat # 8242s) for 2 h,
stained with Alexa fluor 594-labeled secondary antibody (Thermo Fisher Scientific, Cat # A-
11005) for 1 h, counterstained with DAPI, and examined by confocal microscopy. Numbers of
GFP expressing cells (approximately 300 cells/sample) exhibiting nuclear NF-κB-p65 staining
were determined in randomly selected fields and results were shown as mean percentage of
GFP/ORFV119GFP expressing cells containing nuclear NF-κB-p65 over three independent
experiments. Statistical analysis of data was performed by using the Student’s t test.
To examine the role of ORFV119 on NF-κB-p65 nuclear translocation during ORFV infec-
tion, OFTu cells were mock infected or infected with OV-IA82, OV-IA82-RV119Flag, OV-
IA82-Δ119 or OV-IA82-RV119LxGxE-Flag (MOI, 10). Cells were fixed at 30 min, 1 h, 2 h, 4 h,
and 6 h p.i. and processed for NF-κB-p65 staining as described above. Cells (approximately
300/sample) were randomly selected and scored as mean percentage of cells containing
nuclear NF-κB-p65 over three independent experiments. Statistical analysis of data was per-
formed by using Student’s t test.
To investigate the effects of CHX on NF-κB-p65 nuclear translocation during ORFV infec-
tion, OFTu cells were pre-treated with CHX for 30 min, infected with OV-IA82 or OV-IA82-
Δ119 in presence or absence of CHX, and fixed at 30 min or 1 h p.i. NF-κB-p65 nuclear trans-
location assay, scoring, quantification and analysis were performed as described above.
To investigate the effect of OV-IA82, OV-IA82Rb-, OV-IA82-RV119LxGxE-Flag and
OV-IA82-RV119LxGxE-Flag-Rb- virus infection on NF-κB-p65 nuclear translocation, OFTu or
OFTuRb- cells were infected with OV-IA82, OV-IA82Rb-, OV-IA82-RV119LxGxE-Flag or
OV-IA82-RV119LxGxE-Flag-Rb- virus (MOI, 10). Cells were fixed at 1 h p.i. and NF-κB-p65
nuclear translocation assay was performed as described above. Cells (approximately 300/sam-
ple) were randomly selected and scored for mean percentage of cells containing nuclear NF-
κB-p65 over two independent experiments. Statistical analysis of data was performed by using
Student’s t test.
Additionally, to assess the effect of pRb on NF-κB-p65 nuclear translocation, Saos-2 cells, a
pRb negative cell line, were mock infected or infected with OV-IA82 or OV-IA82-Δ119 (MOI,
50) and fixed at 1 h, 1.5 h, 2 h, 4 h, and 6 h p.i. NF-κB-p65 nuclear translocation assay, quantifi-
cation and analysis were performed as described above.
Effect of ORFV119 expression on NF-κB-p65 signaling
HeLa cells transfected with control plasmid (pFlag) or a plasmid encoding ORFV119-3xFlag
fusion protein (pORFV119Flag) were treated with TNFα (20ng/ml), and harvested 10 and 20
min post treatment. OFTu cells mock infected or infected with OV-IA82, OV-IA82-RV119Flag,
OV-IA82-Δ119 or OV-IA82-RV119LxGxE-Flag (MOI, 10) were harvested at 30 min and 1 h p.i.
Total protein extracts (50 μg) were resolved by SDS-PAGE, blotted and transferred to nitrocel-
lulose membranes and probed with specific antibody against phospho-IKKα/β (Ser176/180)
(Cat # 2697; Cell Signaling), phospho-IκBα (Ser32/36) (Cat # 9246; Cell Signaling), phospho-
NF-κB-p65 (Ser536) (Cat # 3033; Cell Signaling), IKKα/β (sc-7607; Santa Cruz), IκBα (sc-371;
Santa Cruz), NF-κB-p65 (sc-7151; Santa Cruz) and GAPDH (sc-25778; Santa Cruz) or Flag.
Blots were processed as described above. Protein bands were quantified for densitometric
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analysis using ImageJ software, Version 1.6.0 (National Institute of Health, Bethesda, MD) and
fold changes calculated. Statistical analysis was performed by using Student’s t test.
To investigate the effect of ORFV infection on NF-κB-p65 activation, OFTu cells were
infected with OV-IA82 or OV-IA82-Δ119 (MOI, 10) and harvested at 30 min, 1 h, 2 h, 4 h,
and 6 h p.i. Total protein extract (50 μg) were resolved by SDS-PAGE, blotted and transferred
to nitrocellulose membranes, probed with phospho-NF-κB-p65 and NF-κB-p65 antibodies,
and developed as described above.
Luciferase assays
The effect of ORFV119 on poly(I:C), poly(A:T) or ORFV DNA induced NF-κB-mediated tran-
scriptional activity was investigated using a NF-κB promoter luciferase assay. Firefly luciferase
gene under the control of NF-κB promoter (pNF-κB-Luc) and with a plasmid encoding sea
pansy (Renilla reniformis) luciferase under the control of herpesvirus TK promoter (pRL-TK)
were used in studies. HeLa cells cultured in 12-well plates were co-transfected with the vectors
pNF-κB-Luc (450 ng; Clontech, Mountain View, CA), and pRL-TK (50 ng; Promega, Madison,
WI) and pFlag or pORFV119Flag. At 24 h after transfection, cells were induced with poly(I:C)
(Amersham, Pittsburgh, PA (500ng), poly(A:T) (Inviogen, San Diego, CA) (750ng) or ORFV
DNA (1μg). ORFV DNA was extracted from OV-IA82 virus stock using QIAamp DNA Blood
Mini Kit (Qiagen, Germantown, MD). Luciferase activities were determined at 20 h post-
induction using the Dual Luciferase Reporter Assay (Promega) and a luminometer. Data were
analyzed as previously described [35]. Statistical analysis of the data was performed by using
Student’s t test.
To investigate the effect of ORFV119 on E2F transcriptional activity in ORFV infected cells,
OFTu cells were co-transfected with a pE2F-Luc (450 ng; Signosis, Santa Clara, CA) and
pRL-TK (50 ng) plasmids. At 24 h post transfection, cells were mock infected or infected with
OV-IA82, OV-IA82Δ119, or OV-IA82-RV119LxGxE-Flag (MOI = 10). Firefly and sea pansy
luciferase activities were measured at 1, 2, 4 and 6 h p.i. and expressed as relative fold changes
in luciferase activity as described above.
Co-immunoprecipitation
The interaction of ORFV119 or ORFV119LxGxE with pRb and ORFV119 with TRAF2 was
assessed in virus-infected cells by co-immunoprecipitation. OFTu cells infected with OV-
IA82-RV119Flag or OV-IA82-RV119LxGxE-Flag (MOI, 10) or mock infected were harvested at
12 h p.i. Total protein extraction and co-immunoprecipitation was performed using nuclear
complex Co-IP Kit (Active Motif, Carlsbad, CA) following the manufacturer’s instructions.
For co-immunoprecipitation, total protein extracts were incubated with antibodies against
Flag, TRAF2 and pRb in the high stringency buffer (IP High buffer [Cat # 101676], 300 mM
NaCl [Cat # 101684], detergent [Cat # 101683], 1M DTT [Cat # 3483-12-3; sigma], Protease
inhibitor cocktail [Cat # P8340; sigma]) overnight at 4˚C, and then incubated with pre-washed
50 μl slurry of protein G agarose beads (Cat # 16–266; Millipore) at 4˚C for 2 h. Beads were
washed four times with high stringency buffer (described above) and bound proteins were
eluted in Laemmli buffer. For immunoblot analysis, eluted proteins and control total protein
cell lysates were resolved by SDS-PAGE, blotted and transferred to nitrocellulose membranes,
probed with antibodies against Flag, TRAF2 and pRb and developed as described above. Light
chain specific antibody against Rabbit IgG (Cat # ab99697; Abcam) was used for TRAF2 blots.
A flag-expressing protein ORFV113Flag was used as a control for specificity of ORFV119 and
TRAF2 interaction.
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The interaction of pRb with TRAF2 in the presence of pORFV119Flag also was assessed by
co-immunoprecipitation. Antibodies for co-immunoprecipitation included anti-pRb (Cat #
9309s, Cell Signaling), anti-TRAF2 (Cat # sc-876, Santa cruz) and anti-Flag. Co-immunopre-
cipitations of total proteins extracts were performed as described above. The interaction of
ORFV119 or ORFV119LxGxE with putative cellular binding partners was assessed by co-immu-
noprecipitation in pORFV119Flag or pORFV119LxGxE-Flag transfected HEK 293T or HeLa cells
at 12 h post transfection. Antibodies for co-immunoprecipitation included pRb (Fig 3A, B-Cat
# ab85607, abcam) (Fig 3E, F-Cat # 9309s, Cell Signaling), TRAF2 (Cat # sc-876, Santa cruz),
TAK1 (Cat # sc-7126, Santa cruz), RIP1 (Cat # 3493, cell signaling), TRAF6 (sc-7221) or
NEMO (sc-8330). Co-immunoprecipitations of total proteins extracts were performed as
described above.
The interaction of ORFV119 with TRAF2 also was assessed in Saos-2 cells, which do not
express pRb. Saos-2 cells transfected with control plasmid (pFlag) and pORFV119Flag or co-
transfected with pRb (Origene, Rockville, MD) were harvested at 12h post transfection. Co-
immunoprecipitations of total proteins extracts were performed as described above. Antibod-
ies for co-immunoprecipitation included anti-TRAF2, anti-Flag and anti-pRb.
Co-immunoprecipitation efficiency was calculated by normalizing the band intensities of
co-immunoprecipitated proteins to those corresponding immunoprecipitated proteins and to
the expression of corresponding input lysates as previously described [50].
Animal inoculations
Five-month-old lambs randomly allocated to three experimental groups were inoculated with
either OV-IA82-Δ119 (n = 4) or OV-IA82-RV119Flag (n = 4), or mock-infected (n = 3). Fol-
lowing anesthesia, the mucocutaneous junction of the right lower lip near the labial commis-
sure was scarified along a two-centimeter line, and virus inoculum (0.5 ml) containing 107.5
TCID50/ml was applied topically using cotton swabs. In addition, the inner sides of hind
limbs were scarified in a five-centimeter line and inoculated as above. Animals were moni-
tored for 21 days for the presence of characteristic orf lesions. Pictures were taken of the labial
inoculation sites at days 3, 5, 9, 12, 16 and 21 p.i. and the lesion sizes measured with a ruler.
Skin biopsy specimens from hind limb inoculation sites were collected at days 2, 5, 8, 12 and
21 p.i. fixed in 10% buffered formalin, embedded in paraffin, sectioned, and stained with
hematoxylin and eosin using standard methods.
Ethics statement
All animal procedures were approved by University of Nebraska-Lincoln Institutional Animal
Care and Use Committee (IACUC; protocol 1318) and were performed in accordance with
the Guide for the Care and Use of Agricultural Animals in Agricultural Research and
Teaching.
Accession numbers of virus strains used in ORFV119 sequence analysis
PPV ORFV119 amino acid sequences were aligned using Clustal Omega (EMBL-EBI). ORFV
GeneBank accession numbers are (virus strains in parentheses) AY386263 (OV-IA82), AAP89
015 (Orf11), ABA00637 (NZ2), 9AHH34303 (B029), ADY76823 (D1701), NP957896 (OV-
SA00), AKU76741 (OV-GO), AKU76609 (OV-YX), AHZ33817 (NA1/11) and KP010356
(OV-SJ1). PCPV and BPSV GeneBank accession numbers are AEL20654 (PCPV F00-120R),
AEO18268 (PCPV It1303/05), NP958027 (BPSV BV-AR02) and KM875471 (BPSV BV-
TX09c5).
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Results
ORFV119 is a nonessential early LxCxE motif-containing protein
ORFV119 encodes for proteins of 170 to 206 amino acids, with predicted molecular weights of
18.6 to 22.2 kDa and percentage amino acid identities ranging from 77% to 100% (Fig 1). Homo-
logs in Pseudocowpox virus (PCPV) and Bovine papular stomatitis virus (BPSV) are 89% and
54–56% identical to OV-IA82 ORFV119, respectively, whereas no ORFV119 homologue was
found in the HL953 strain of parapoxvirus of red deer in New Zealand [51]. ORFV119 lacks
homology to known proteins outside the PPV genus, and domains suggestive of protein func-
tion. However, a LxCxE motif (OV-IA82 ORFV119 positions 192–196) and a downstream
stretch of acidic amino acids usually found in LxCxE motif-containing proteins are located at
the C-terminus of the protein and highly conserved in PPV119 proteins (Fig 1). The LxCxE
motif is required by several cellular and viral proteins to interact with members of the retinoblas-
toma family of proteins, which controls important aspects of cell physiology, including cell cycle
progression, differentiation, and apoptosis [52]. The ORFV119 LxCxE motif and surrounding
sequences follow the pattern XLXCXEXXX, where X should not be a positively charged amino
acid (e.g. Lys or Arg) and X should preferably be a hydrophobic residue, which is predicted to
bind pRb with high affinity [46]. A predicted mitochondrial localization sequence is found in the
N-terminus of most ORFV strains and in PCPV (underlined in Fig 1), but not in BPSV119.
The kinetics of ORFV119 was assessed during ORFV replication in OFTu cells by Western
blot using a recombinant virus expressing N-terminally Flag-tagged ORFV119 (OV-IA82-
RV119Flag). A protein of approximately 32 kDa was detected at 2 h p.i. with increasing protein lev-
els observed at later time points. At 24 h p.i., the last time point investigated, an additional slightly
higher molecular weight species of ORFV119 (approximately 35 kDa) was detected (Fig 2A). The
observed protein molecular weight was approximately 10 kDa higher than predicted, suggesting
that the protein is post-translationally modified in some manner. Previous reports on ORFV rep-
lication have shown that early genes were expressed as early as 1 h p.i., with late genes expressed
between 6 to 12 h p.i [35–38]. Newly replicated viral DNA was first detectable at 4 to 6 h p.i. accu-
mulating rapidly between 8 and 16 h p.i [53]. Infectious virus was detected between 16 and 18 h
p.i., with continuous virus production until 40 h p.i. [53]. Thus, ORFV119 is a early viral protein.
OV-IA82-Δ119, a virus lacking the ORFV119 gene, exhibited growth kinetics and virus
yields comparable to those of wild type OV-IA82 and revertant OV-IA82-RV119Flag viruses in
single step growth curves in OFTu cells, indicating that the gene is non-essential for growth in
these cells (S1 Fig).
To examine the intracellular localization of ORFV119, OFTu cells were infected with
OV-IA82-RV119Flag and examined by confocal microscopy at various times post-infection.
ORFV119 staining was not evident at 3 and 6 h time points. At 12 h p.i., weak punctate
ORFV119 staining was observed in the cytoplasm and adjacent to the plasma membrane. By 16
h p.i., enhanced ORFV119 staining was evident, and fluorescent circular to ovoid structures (389
±30nm) were observed in the cytoplasm and especially in close proximity to the cell membrane.
Remarkably, at late times p.i. (24 h), OV-IA82-RV119Flag infected cells exhibited abundant
ORFV119 nuclear staining (Fig 2B). Fluorescence was specific for Flag-tagged ORFV119 as no
signal was observed in cells infected with OV-IA82-Δ119 at all examined times p.i. (Fig 2B).
ORFV119 interacts with the retinoblastoma protein (pRb) in an LxCxE
motif-dependent manner
To investigate whether ORFV119 interacts with retinoblastoma protein pRb, 293T and HeLa
cells were transfected with plasmids pORFV119Flag (ORFV119Flag), pORFV119LxGxE-Flag
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(ORFV119LxGxE) or control plasmid (pFlag), and protein extracts were prepared at 12 h
post-transfection. Reciprocal co-immunoprecipitation assays with either anti-Flag or anti-pRb
antibodies demonstrated that ORFV119 co-immunoprecipitates with pRb in both cell types.
Fig 1. Clustal W alignment of PPV119 amino acid sequences. Aligned sequences are ORFV strains
OV-IA82, NZ2, OV-SJ1, OV-XY, OV-SA00, OV-GO, D1701, NA1/11, ORF11, and B029, PCPV strains
F00.120R and It1303/05, and BPSV strains BV-AR02 and BV-TX09c5 (see Materials and Methods for
accession numbers). Numbers on the right indicate amino acid positions for OV-IA82 strain ORFV119.
Shaded columns, boxed sequences and the underlined sequence correspond to the conserved LxCxE motif,
the acidic-rich region, and the predicted mitochondrial localization signal, respectively. Asterisks [*], colons [:],
and periods [.] below the alignment indicate fully, strongly, and weakly conserved, residues, respectively.
https://doi.org/10.1371/journal.ppat.1006779.g001
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Co-immunoprecipitation of ORFV119 and pRb, however, was not observed with pORFV
119LxGxE-Flag, a plasmid encoding ORFV119 in which C in the LxCxE motif was replaced
by G, a change shown to abrogate interaction with pRb (Figs 3A and 3B, S2) [54]. To con-
firm the interaction in the context of the virus infection, OFTu cells were mock-infected or
infected with OV-IA82-RV119Flag or OV-IA82-RV119LxGxE-Flag (MOI, 10), and cell lysates
Fig 2. (A) Kinetics of ORFV119 expression. OFTu cells infected with OV-IA82 or revertant virus OV-IA82-
RV119Flag (MOI, 10) were harvested at indicated times p.i. Total cell protein extracts were resolved by
SDS-PAGE, blotted and incubated with antibodies against Flag and GAPDH. M, mock; GAPDH, control.
Results are representative of two independent experiments. (B) ORFV119 subcellular localization. OFTu cells
were mock infected or infected with OV-IA82-Δ119 or OV-IA82-RV119Flag (MOI, 10), fixed at indicated times
p.i. sequentially incubated with mouse monoclonal primary antibody against Flag and Alexa flour 594 labeled
secondary antibody, counterstained with DAPI and examined by confocal microscopy. Insets show magnified
areas of the field. ORFV119 staining is highlighted within the white box at 16 h p.i.
https://doi.org/10.1371/journal.ppat.1006779.g002
ORFV119 inhibits NF-κB signaling
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006779 December 15, 2017 12 / 36
Fig 3. ORFV119 interacts with pRb. (A and B). 293T cells were transfected with plasmids pORFV119Flag
(p119Flag), pORFV119LxGxE-Flag (p119LxGxE-Flag) or control plasmid (pFlag) and harvested at 12 h post
transfection. Total cell lysate (CL) and protein extracts immunoprecipitated (IP) with anti-Flag (A) or anti-pRb
(B) antibodies were examined by Western blot (WB) with antibodies against Flag or pRb. Results are
representative of four independent experiments. (C-F) OFTu cells were mock infected or infected with
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prepared at 12 h p.i. Reciprocal co-immunoprecipitation with either anti-Flag or anti pRb
antibodies showed that ORFV119 but not ORFV119LxGxE-Flag co-immunoprecipitates with
pRb (Fig 3C–3F). Together, these results indicate that ORFV119 directly or indirectly
interacts with pRb. The observation that the integrity of the LxCxE motif is required for the
interaction further suggests that ORFV119 might directly bind pRb.
ORFV119 inhibits NF-κB-signaling and NF-κB-p65 nuclear translocation
early during infection
Preliminary RNA-Seq experiments indicated increased transcription of multiple NF-κB regu-
lated genes in cells infected with OV-IA82-Δ119 compared to cells infected with OV-IA82
virus, suggesting that ORFV119 inhibits NF-κB signaling. To rule out any confounding effect
from cytokines that potentially might be present in the virus inocula, viruses used in these
studies were semi-purified as described in Materials and Methods. Real-time PCR analysis of
gene expression showed increased levels of NF-κB-regulated genes TNFα (6.68-fold), TLR2
(6.48-fold), NF-κB1 (3.26-fold) and IL36α (3.7-fold) in cells infected with OV-IA82-Δ119
compared to OV-IA82 at 2 h p.i (Fig 4A).
To assess the effect of ORFV119 on NF-κB-p65 nuclear translocation, OFTu cells were
mock infected or infected with OV-IA82, OV-IA82-Δ119, OV-IA82-RV119LxGxE-Flag or
OV-IA82-RV119Flag and NF-κB-p65 localization was examined by immunofluorescence.
Infection with OV-IA82-Δ119 and OV-IA82-RV119LxGxE-Flag but not OV-IA82 or OV-
IA82-RV119Flag led to rapid nuclear translocation of NF-κB-p65 as early as 30 min p.i. (Fig
4B and 4C). The effect was transient as the percentage of cells expressing nuclear NF-κB-
p65 returned to those in wild type and revertant virus-infected cells between 1 and 2 h p.i.
(Fig 4C, P<0.05). Notably, levels of NF-κB-p65 nuclear translocation observed for OV-
IA82-RV119LxGxE-Flag were significantly reduced compared to those observed with OV-
IA82-Δ119 (Fig 4C). Consistent with the nuclear translocation kinetics, levels of phosphory-
lated NF-κB-p65 (Ser536), which accumulates in the cytoplasm prior to nuclear transloca-
tion, were increased at early times p.i. (30 min and 1 h) with OV-IA82-Δ119 (S3 Fig).
Together, these data show that ORFV119 is a poxviral NF-κB inhibitor acting transiently
very early in infection and that ORFV119 LxCxE motif is important for the full inhibitory
activity of the protein.
To explore the possibility that pRb transcriptional activity is involved in ORFV119 inhibition
of NF-κB signaling in virus infected cells, we examined E2F-mediated gene transcription early
in infection. OFTu cells were transfected with a plasmid encoding for a firefly luciferase reporter
gene under the control of a E2F-responsive promoter and at 24 h post transfection cells were
mock infected or infected with OV-IA82, OV-IA82Δ119 or OV-IA82-RV119LxGxE-Flag. Lucifer-
ase activities were measured at 1, 2, 4 and 6 h p.i. Similar low luciferase activity was observed in
mock and virus-infected cells at 1, 2 and 4 h p.i. Significantly higher luciferase activity was
observed in virus infected cells at 6 h p.i.; however, no significant difference was observed
among the three viruses (S4 Fig). Thus, data suggest that ORFV119 mediated NF-κB inhibition
does not involve E2F-mediated gene transcription early in infection.
OV-IA82-RV119Flag (C and D), OV-IA82-RV119LxGxE-Flag (E and F) (MOI, 10) and harvested at 12 h p.i. Total
cell lysate and protein extracts immunoprecipitated with anti-Flag (C and E) or anti-pRb (D and F) antibodies
were examined by Western blot with antibodies against Flag or pRb. Results are representative of three
independent experiments. Percentage of (A) pRb co-immunoprecipitated by ORFV119Flag: 16.7±1.2%; (B)
ORFV119Flag co-immunoprecipitaed by pRb: 28.4±2.3%; (C) pRb co-immunoprecipitated by ORFV119Flag in
OV-IA82-RV119Flag infected cells: 8.7±1.4%; (D) ORFV119Flag co-immunoprecipitated by pRb in
OV-IA82-RV119Flag infected cells: 18.5±1.91%.
https://doi.org/10.1371/journal.ppat.1006779.g003
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Fig 4. (A) Effect of ORFV119 on NF-κB mediated gene expression. OFTu cells were infected with OV-IA82,
OV-IA82-Δ119, or OV-IA82-RV119Flag (MOI, 10), and levels of TNFα, TLR2, NF-κB1 and IL36αmRNA
assessed by real-time PCR at 2 h p.i. Fold changes are relative to OV-IA82 treatment. Results are the mean
values of three independent experiments. (*, P<0.05; **, P<0.01). (B)—Effect of ORFV119 on NF-κB-p65
ORFV119 inhibits NF-κB signaling
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Infection with OV-IA82Δ119 results in increased phosphorylation of
IKKα/β, IκBα and NF-κB-p65 early in infection
To further investigate the mechanism of ORFV119 in NF-κB inhibition, OFTu cells were
mock-infected or infected with OV-IA82, OV-IA82-Δ119, OV-IA82-RV119LxGxE-Flag or
OV-IA82-RV119Flag for 30 min or 1 h p.i. and phosphorylation of IKKα/β, IκBα and NF-κB-
p65 was assessed by Western blot. Infection by OV-IA82Δ119 and OV-IA82-RV119LxGxE-Flag
led to marked and early phosphorylation of IKKα/β (Ser176/180), IκBα (Ser32/36) and NF-
κB-p65 (Ser536) compared to OV-IA82 infected cells (Fig 5A). In OV-IA82Δ119-infected
cells, relative fold increases of phosphorylated IKKα/β (14.5 and 19.7 fold), IκBα (21.5 and
11.23 fold) and NF-κB-p65 (9.24 and 15.35 fold) were observed at 30 min and 1 h p.i., respec-
tively (Fig 5B and 5C). Similarly, in OV-IA82-RV119LxGxE-Flag-infected cells, relative fold
increases of phosphorylated IKKα/β (27.35 and 21.42 fold), IκBα (19.35 and 21.24 fold) and
NF-κB-p65 (13 and 13.24 fold) were observed at 30 min and 1 h p.i., respectively (Fig 5B and
5C). These results indicate that ORFV119 inhibits phosphorylation of the IKK complex, a NF-
κB activating event.
ORFV119 is a virion protein and its early NF-κB inhibitory activity does
not involve de novo viral protein synthesis
The observation of ORFV119 staining structures of approximate virion size in infected cells at
16 h p.i. (Fig 2B) together with the early inhibitory effect of ORFV119 on NF-κB signaling sug-
gested ORFV119 may be a virion component available during and/or immediately after virus
entry. To examine this possibility, extracellular enveloped virus (EEV) and intracellular mature
virus (IMV) were purified from OFTu cells infected with an OV-IA82, OV-IA82-Δ119, OV-
IA82-RV119LxGxE-Flag and OV-IA82-RV119Flag virus. As in infected cell extracts at 24 h p.i.
(Fig 2A), western blot analysis showed a protein doublet (~32 and 35 kDa) corresponding to
ORFV119Flag or ORFV119LxGxE-Flag in both virion fractions. As expected, the ORFV119 protein
was not detected in OV-IA82 (ORFV119 lacks Flag tag) and OV-IA82-Δ119 virions (Fig 6A). A
control virion core protein ORFV086 was detected as a predominant 21 kDa band in OV-IA82,
OV-IA82-Δ119, OV-IA82-RV119LxGxE-Flag and OV-IA82-RV119Flag EEV and IMV virions [49]
(Fig 6A). As a control for potential contamination of purified virions with cellular proteins, a
GAPDH control was used. GAPDH protein was not detected in OV-IA82, OV-IA82-Δ119,
OV-IA82-RV119LxGxE-Flag and OV-IA82-RV119Flag purified EEV and IMV virions (Fig 6A).
To assess whether early inhibition of NF-κB-p65 nuclear translocation by ORFV119
involves de novo viral protein synthesis in the infected cells, OFTu cells were pre-treated with
the protein synthesis inhibitor cycloheximide (CHX) for 30 min followed by infection with
OV-IA82 or OV-IA82-x119 for 30 min and 1 h in presence of the drug. If de novo synthesis of
ORFV119 is required for inhibiting NF-κB signaling, then increased levels of NF-κB activation
should be observed in OV-IA82 infected CHX treated cells. Low levels of ORFV119 proteins
were detected at 30 min and 1 h p.i. likely representing input virion-associated protein;
phosphorylation and nuclear translocation. OFTu cells were mock infected or infected with OV-IA82,
OV-IA82-Δ119, OV-IA82-RV119Flag, or OV-IA82-RV119LxGxE-Flag (MOI, 10), fixed at 1 h p.i, sequentially
incubated with primary antibody against NF-κB-p65 and appropriate Alexa Fluor 488 or 594 labeled
secondary antibodies, counterstained with DAPI, and examined by confocal microscopy. Green/Red, NF-κB-
p65; Blue, DAPI. Results are representative of three independent experiments. (C) OFTu cells were infected
and processed as in B, and the percentage of cells exhibiting nuclear NF-κB-p65 calculated at the indicated
time points p.i. Results are shown as mean ± S.D. (n = 300 cells/slide) for three independent experiments [*,
P<0.05 (OV-IA82 vs OV-IA82-Δ119 and OV-IA82 vs OV-IA82-RV119LxGxE-Flag), #P<0.05, ##P<0.01
(OV-IA82-Δ119 Vs OV-IA82-RV119LxGxE-Flag)].
https://doi.org/10.1371/journal.ppat.1006779.g004
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Fig 5. Effect of ORFV119 on IKKα/β, IκBα and NF-κB-p65 phosphorylation. (A) OFTu cells were mock infected
or infected with OV-IA82, OV-IA82-Δ119, OV-IA82-RV119LxGxE-Flag or OV-IA82-RV119Flag viruses (MOI, 10) and
harvested at the indicated times p.i. Total cell protein extracts (50 μg) were resolved by SDS-PAGE, blotted, and
probed with specific antibodies shown on the right. Results are representative of three independent experiments. (B
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however, ORFV119 protein levels declined in CHX-treated OV-IA82-RV119Flag infected
OFTu cells at subsequent times (Fig 6B). Under these treatment conditions, expression of con-
trol host protein p53 also was inhibited (Fig 6C). Immunofluorescence analysis showed that
inhibition of NF-κB-p65 nuclear translocation was unaltered in OV-IA82 infected cells regard-
less of CHX treatment (Fig 6D and 6E). Together, these results indicate that ORFV119 is a
virion component, and suggest that virion-associated ORFV119 alone is responsible for early
inhibition of NF-κB signaling.
ORFV119 alone is sufficient for inhibiting TNFα-induced NF-κB signaling
in non-infected cells
To determine if ORFV119 alone is sufficient for inhibiting TNFα-induced nuclear transloca-
tion of NF-κB-p65, immunofluorescence assays were performed in HeLa cells transiently
expressing GFP or ORFV119-GFP fusion protein (119GFP). Following TNFα induction (30
min) ORFV119-GFP-expressing cells exhibited significantly reduced nuclear translocation of
NF-κB-p65 (12.7%) compared to control cells expressing GFP alone (68%) (Fig 7A and 7B,
P<0.05).
ORFV119 effect on TNFα induced activation of NF-κB-p65 was further investigated by
examining phosphorylation of IKKα/β (Ser176/180), IκBα (Ser32/36) and NF-κB-p65 (Ser536)
in HeLa cells transfected with pFlag or pORFV119Flag plasmids. ORFV119 expression markedly
reduced the TNFα induced phosphorylation of IKKα/β (20 and 50%), IκBα (25 and 68%) and
NF-κB-p65 (40 and 60%) in cells expressing ORFV119Flag compared to control pFlag expressing
cells at 10 and 20 min after TNFα induction. (Fig 8A–8D, P<0.05 and P<0.01). Together, results
indicate that ORFV119 inhibits TNFα-induced NF-κB signaling by preventing activation of the
IKK complex in the absence of any other viral protein.
To examine if ORFV119 also affected poly(I:C), poly(A:T) or ORFV DNA-induced NF-κB
transcriptional activity, HeLa cells were co-transfected with pFlag or pORFV119Flag together
with a plasmid encoding for a firefly luciferase reporter gene under the control of a NF-κB-
responsive promoter. Cells were induced with poly(I:C), poly(A:T) or ORFV DNA at 24 h
post-transfection and luciferase activities were determined at 20 h post-induction. No signifi-
cant effect of ORFV119 expression on poly(I:C), poly(A:T) or ORFV DNA-induced NF-κB-
mediated transcription was observed (S5 Fig). Thus, data suggest that ORFV119 functions pri-
marily through TNFα-induced NF-κB signaling.
pRb affects ORFV119 inhibition of NF-κB signaling
Given that: 1) ORFV119 interacts with pRb (Fig 3), 2) the ORFV119 LxCxE motif is required
for that interaction (Fig 3) and 3) OV-IA82-RV119LxGxE-Flag—a virus containing a mutation in
the ORFV119 LxCxE motif that abrogates pRb binding—was unable to efficiently inhibit NF-
κB signaling (Fig 5), we examined the involvement of pRb in ORFV119-mediated inhibition
of NF-κB signaling and NF-κB-p65 nuclear translocation in cells either lacking or with
reduced levels of pRb.
Cells with reduced levels of pRb (OFTuRb-) were prepared from OFTu cells using siRNAs
targeting ovine RB1 (see Materials and Methods). pRb protein knockdown of approximately
60% was routinely obtained for RB1 siRNA-transfected cells at 48 h post-transfection (Fig 9A,
and C) Densitometric analysis of bands corresponding to phosphorylated IKKα/β, IκBα and NF-κB-p65 at 30 min
(B) and 1 h p.i. (C). Densitometry of p-IKKα/β, p-IκBα and p-NF-κB-p65 bands were normalized to the loading
control GAPDH. Fold changes are shown relative to OV-IA82 treatment and results are mean values of three
independent experiments. (*P < 0.05) (OV-IA82 vs OV-IA82-Δ119 and OV-IA82 vs OV-IA82-RV119LxGxE-Flag).
https://doi.org/10.1371/journal.ppat.1006779.g005
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Fig 6. (A) Detection of ORFV119 or ORFV119LxGxE in virions. OFTu cells were infected with OV-IA82,
OV-IA82-Δ119 (Δ119), OV-IA82-RV119LxGxE-Flag (RV119LxGxE) or OV-IA82-RV119Flag (RV119Flag) and IMV
and EEV virions were purified as described in Materials and Methods. Whole cell lysate (W.C.L) (60 μg) from
OV-IA82-RV119Flag infected OFTu cells, and purified virions (10 μg) were resolved by SDS-PAGE and
analyzed by Western blot using antibodies against Flag, ORFV086 structural core protein (positive control) or
GAPDH. Results are representative of three independent experiments. (B, C) Effect of translation inhibition on
ORFV119 and control cellular protein p53 expression. OFTu cells mock treated or pre-treated with CHX
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lanes 2 and 3). Given the possibility that pRb may be associated with the virion due to its inter-
action with ORFV119, virus stocks were prepared in either OFTu or OFTuRb- cells (see Materi-
als and Methods). To evaluate the effect of reduced pRb levels on ORFV119 ability to inhibit
NF-κB signaling, NF-κB-p65 nuclear translocation assays were performed in OFTu or OFTuRb-
cells using OV-IA82, OV-IA82Rb- (OV-IA82 virus propagated in cells with reduced pRb levels),
OV-IA82-RV119LxGxE-Flag or OV-IA82-RV119LxGxE-Flag-Rb- virus (OV-IA82-RV119LxGxE-Flag
virus propagated in cells with reduced pRb levels) virus stocks. As expected from data described
above for OV-IA82 (Figs 4 and 5), levels of NF-κB-p65 nuclear translocation at 1 h p.i. following
infection of OFTu cells using OV-IA82 virus were low (1.5% positive nuclei). However, signifi-
cantly increased NF-κB-p65 nuclear translocation was observed for treatment conditions where
either OFTuRb- cells (OFTuRb- cells/ OV-IA82 virus) or OV-IA82Rb- virus (OFTu cells/ OV-
IA82Rb- virus) were used (6.1 and 6.5% NF-κB-p65 positive nuclei, respectively). Notably, using
both OFTuRb- cells and OV-IA82Rb- virus resulted in significantly increased levels of NF-κB-
p65 nuclear translocation in infected cells (17.2% NF-κB-p65 positive nuclei) (Fig 9B and 9C).
As expected for a ORFV119 protein lacking the pRb binding motif (LxCxE), no significant dif-
ference was observed in NF-κB-p65 nuclear translocation for treatment conditions where
OV-IA82-RV119LxGxE-Flag or OV-IA82-RV119LxGxE-Flag-Rb- viruses were used to infect either
OFTu or OFTuRb- cells (44.25% and 49.2% NF-κB-p65 positive nuclei, respectively) (S6 Fig).
Thus, pRb contributes to the ORFV119-mediated inhibition of NF-κB signaling in infected
OFTu cells.
Additional experiments examining involvement of pRb in ORFV119-mediated inhibition
of NF-κB signaling were conducted in human osteosarcoma Saos-2 cells, a pRb-deficient cell
line [55]. pRb was not detected in Saos-2 cell extracts by western blot. (Fig 9A, Lane1). If pRb
is mediating ORFV119 inhibition of NF-κB-p65 nuclear translocation, increased NF-κB-p65
nuclear translocation would be expected in OV-IA82 virus infected Saos-2 cells. Saos-2 cells
were mock infected or infected with OV-IA82 or OV-IA82-Δ119 and NF-κB-p65 localization
was examined by immunofluorescence at indicated times p.i. No significant differences in NF-
κB-p65 positive nuclei in OV-IA82-or OV-IA82-Δ119-infected cells were observed at any time
post-infection (Fig 10A and 10B). Thus, in the absence of pRb, the early NF-κB inhibitory phe-
notype observed for OV-IA82 is lost. Together, data using cells with reduced pRb levels or
lacking pRb altogether indicate that ORFV119-mediated inhibition of NF-κB-signaling is
largely pRb-dependent.
ORFV119 interacts with TRAF2, a component of the NF-κB signaling
pathway
To assess potential interactions of ORFV119 with components of the TNFα-induced NF-κB
signaling pathway, co-immunoprecipitation assays were conducted with antibodies against
TRAF2, TAK1, RIP1, TRAF6 and NEMO. OFTu cells were mock-infected or infected with
OV-IA82-RV119Flag (MOI, 10) and harvested at 12 h p.i. Total cell protein extracts were
immunoprecipitated with anti-Flag or anti-target cellular protein antibodies. Reciprocal
(50 μg/ml) for 30 min were mock infected or infected with OV-IA82-RV119Flag (MOI, 10) in presence of the
drug and harvested at 0.5 h, 1 h, 1.5 h, and 2 h p.i. Cell extracts (50 μg) were resolved by SDS-PAGE, blotted,
and probed with anti-Flag, anti-p53 and anti-GAPDH antibodies. (D, E) OFTu cells were drug treated and
infected as in B with OV-IA82 or OV-IA82-Δ119 viruses, fixed at 30 min (6D) or 1 h p.i (6E), incubated with
anti-NF-κB-p65 antibody, and examined by confocal microscopy. Cells were counted (n = 300 cells/slide) and
results are shown as percentage of cells expressing nuclear NF-κB-p65. Results are mean values from two
independent experiments. NS, non-significant by Student t test. [OV-IA82 (CHX+) vs OV-IA82 (CHX-),
OV-IA82-Δ119 (CHX+) vs OV-IA82-Δ119 (CHX-)].
https://doi.org/10.1371/journal.ppat.1006779.g006
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co-immunoprecipitation demonstrated that ORFV119 co-immunoprecipitates with TRAF2
(Fig 11A and 11B). Similar results were obtained in 293T cells transiently expressing
pORFV119Flag (Fig 11E and 11F); however, no interaction was observed between TRAF2 and
transiently expressed ORFV119LxGxE (S7 Fig). As a control for specificity of ORFV119 and
TRAF2 interaction, a Flag tagged ORFV113Flag was used. No interaction was observed between
Fig 7. Effect of ORFV119 on TNFα-induced NF-κB-p65 nuclear translocation. (A) HeLa cells were
transfected with control plasmid (pEGFP-N1) or pORFV119-GFP, which expresses ORFV119 fused to
GFP. At 12 h post-transfection, cells were treated with TNFα (20ng/ml) for 30 min and processed for
immunofluorescence. Green, GFP; Red, NF-κB-p65; Blue, DAPI. (B) Cells were counted (n = 500 cells/
slide) and results are shown as percentage of GFP or ORFV119GFP expressing cells with nuclear NF-
κB-p65. Results are mean values of three independent experiments (**P<0.01, GFP vs GFP + TNFα
and GFP + TNFα vs ORFV119-GFP + TNFα). White arrows indicate ORFV119GFP expressing cells with
reduced nuclear NF-κB-p65.
https://doi.org/10.1371/journal.ppat.1006779.g007
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Fig 8. ORFV119 affects TNFα-induced NF-κB activation. (A) HeLa cells transfected with control plasmid (pFlag)
or pORFV119Flag were treated with TNFα (20 ng/ml) at 12 h post-transfection and harvested at the indicated time
points. Total cell protein extracts (50 μg) were resolved by SDS-PAGE, blotted, and probed with specific antibodies
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ORFV113Flag and TRAF2 in OFTu cells infected with OV-IA82-RV113Flag (Fig 11C and 11D)
nor in 293T cells transfected with pORFV113Flag (Fig 11G and 11H). In the context of viral
infection, reciprocal co-immunoprecipitation of ORFV119 with TAK1, RIP1, TRAF6 and
NEMO was not observed. Together, these results indicate that ORFV119 directly or indirectly
interacts with the scaffold protein TRAF2. Further, dependence on a LxCxE motif for interac-
tion suggested that pRb might play a role in ORFV119-TRAF2 complex formation.
pRb enhances ORFV119-TRAF2 interaction
As ORFV119-mediated inhibition of the NF-κB signaling is pRb dependent (Figs 4, 5, 9 and
10) and ORFV119 interacted with TRAF2 in a LxCxE motif-dependent manner (S7 Fig), we
hypothesized that a ORFV119-pRb complex may be required to efficiently interact with
TRAF2. To examine this possibility, 293T cells were transfected with pFlag or pORFV119Flag
and harvested at 12h p.i. Reciprocal co-immunoprecipitation assays using total cellular protein
extracts with either anti-TRAF2 or anti-pRb antibodies demonstrate that TRAF2 and pRb co-
immunoprecipitation, while weak or absent in pFlag transfected cells, is enhanced by the pres-
ence of ORFV119 in pORFV119Flag transfected cells (Fig 12A and 12B).
To further evaluate a pRb requirement for efficient ORFV119-TRAF2 interaction, co-
immunoprecipitation experiments were performed in Saos-2, a pRb-deficient cell line. In con-
trast to results described above (Fig 11), where ORFV119-TRAF2 interaction was observed in
pRb expressing OFTu and 293T cells, no interaction was detected in Saos-2 cells (Fig 12D and
12E). Notably, transfection of Saos-2 cells with both pORFV119 and pRb plasmids restored
the interaction as reciprocal co-immunoprecipitation of ORFV119 and TRAF2 were observed
(Fig 12F and 12G). Taken together, these data indicate that pRb is important for ORFV119-
TRAF2 interaction and, further, they suggest that a ORFV119-pRb complex may be required
for efficient interaction with TRAF2.
ORFV119 affects ORFV virulence in the natural host
The contribution of ORFV119 to virus virulence was investigated in sheep, a natural ORFV
host. Animals were inoculated with OV-IA82-Δ119 (n = 4), OV-IA82-RV119Flag (n = 4) or
PBS (control group, n = 3) in the right labial commissure and the inner side of the thighs, and
disease course was monitored for 21 days. All virus-inoculated animals developed clinical orf
as evidenced by erythema, papules, pustules, and scabby tissue deposition on the lips (S8A
Fig). However, beginning on day 3 p.i., lesions in sheep inoculated with OV-IA82-RV119Flag
were 25% to 90% larger and exhibited more extensive pustules and scabby tissue deposition
than those inoculated with deletion mutant virus (S8A and S8B Fig). By day 16 p.i., lesions in all
sheep inoculated with OV-IA82-Δ119 were resolved. In contrast, three of four sheep inoculated
with OV-IA82-RV119Flag (sheep # 79, #101, and #639) still exhibited well-defined lesions at day
16 p.i. and regressing lesions still were present in two of the animals (#79 and #101) at day 21 p.i.
(end point of the experiment) (S8A Fig). No lesions were observed in PBS-inoculated controls.
Histological examination of punch biopsies collected from the thighs at various times post-infec-
tion showed no significant differences in time to onset and type of skin changes between groups
of virus-inoculated animals. Overall, results indicate that lesion development is more restricted
and time to resolution is reduced in sheep inoculated with OV-IA82-Δ119 compared to rever-
tant virus. Thus, ORFV119 contributes to ORFV virulence in the natural host.
against proteins shown on the right. (B-D) Densitometry of p-IKKα/β (B), p-IκBx (C), and p-NF-κB-p65 (D) were
normalized to the loading control GAPDH. Fold changes in B-D are shown relative to the pFlag treatment. Results
are mean values from two independent experiments (*P < 0.05, **P < 0.01).
https://doi.org/10.1371/journal.ppat.1006779.g008
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Fig 9. pRb affects ORFV119-mediated inhibition of NF-κB signaling in OFTu cells. (A) Western blot
analysis of pRb expression in Saos-2 cells (Lane 1) and OFTu cells untreated (Lane 2) or treated with siRNA
for RB1 (Lane 3) as described in Materials and Methods. Loading control, GAPDH. (B) OFTu or OFTuRb- cells
were infected with OV-IA82, OV-IA82Rb- virus as described in Materials and Methods and cells were fixed at 1
h p.i. sequentially probed with antibody against NF-κB-p65 and Alexa Fluor 594 labeled secondary antibody,
counterstained with DAPI, and examined by confocal microscopy. Red, NF-κB-p65; Blue, DAPI. (C) Cells
were counted (n = 500 cells/slide) and results are shown as percentage of cells expressing nuclear NF-κB-
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Discussion
The NF-κB signaling pathway plays key roles in the skin by regulating innate immune
responses, inflammation, cell survival and cell proliferation [56–58]. Crucial cytoplasmic and
p65. Results are mean values from two independent experiments. *P<0.05 (OV-IA82 virus/OFTu cells vs
OV-IA82 virus/OFTuRb- cells), *P<0.05 (OV-IA82 virus/OFTu cells vs OV-IA82Rb- virus/OFTu cells, **P<0.01
(OV-IA82 virus/OFTu cells vs OV-IA82Rb-/OFTuRb- cells; no significance (NS) for (C) OV-IA82 virus/OFTuRb-
cells vs OV-IA82Rb- virus/OFTu cells.
https://doi.org/10.1371/journal.ppat.1006779.g009
Fig 10. pRb affects ORFV119-mediated inhibition of NF-κB signaling in Saos-2 cells (A) Saos-2 cells were
mock infected or infected with wild-type OV-IA82 or OV-IA82Δ119 (MOI, 50), fixed 1 h p.i. sequentially probed
with primary antibody against NF-κB-p65 and Alexa Fluor 488 labeled secondary antibody, and counterstained
with DAPI. Green, NF-κB-p65; Blue, DAPI. (B) Cells were counted (n = 500 cells/slide) and results are shown
as percentage of cells expressing nuclear NF-κB-p65. Results are mean values from two independent
experiments. p values for OV-IA82 vs OV-IA82Δ119 comparisons at all-time points were not significant.
https://doi.org/10.1371/journal.ppat.1006779.g010
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Fig 11. Co-immunoprecipitation of ORFV119 with TRAF2. (A-D) OFTu cells were mock infected or
infected with OV-IA82-RV119Flag or OV-IA82-RV113Flag (MOI, 10) and harvested at 12 h p.i. Total cell lysate
and protein extracts immunoprecipitated with anti-Flag (A and C) or anti-TRAF2 (B and D) antibodies were
ORFV119 inhibits NF-κB signaling
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006779 December 15, 2017 26 / 36
nuclear events in the signaling pathway are targeted by various proteins encoded by the highly
epitheliotropic ORFV [35–37]. Here, we describe an ORFV protein, ORFV119, that interacts
with pRb and prevents activation of NF-κB signaling very early during infection. Inhibition of
NF-κB-signaling by ORFV119 is largely dependent on its ability to interact with pRb, which
prevents activation of the IKK complex and downstream NF-κB signaling.
ORFV119 was shown to interact with pRb in infected and uninfected cells, indicating that
other ORFV proteins are not required for the interaction. Similar to oncoproteins of small
DNA viruses, binding to pRb was dependent on the ORFV119 LxCxE motif since a CxG
substitution in the motif abrogated the interaction completely (Fig 3). This suggests that
ORFV119, like small DNA virus oncoproteins, might directly bind pRb. Interestingly, another
highly epitheliotropic poxvirus, molluscum contagiosum virus (MCV), encodes a protein
(MC007L) unrelated to ORFV119 that localizes to mitochondria and interacts with pRb
through an LxCxE motif [59]. The function of MC007L in MCV infection is unknown.
pRb has not been previously implicated in antiviral responses against poxviruses; however,
it has been associated with NF-κB modulation by other viruses. For example, transiently
expressed adenovirus E1A, a pRb-binding oncoprotein, was shown to inhibit NF-κB-depen-
dent transcription induced by TNFα, the effect being dependent on E1A/pRb interaction [44].
And pRb was shown to be required for the activation of the NF-κB pathway in response to
vesicular stomatitis virus infection, although viral mechanisms involved were not described
[45].
Through association with pRb, ORFV119 inhibits NF-κB signaling by preventing IKK com-
plex activation (Fig 5), with ORFV119-TRAF2 interaction likely underlying the inhibition (Fig
11). Results suggest that a ORFV119-pRb complex may be required for efficient interaction of
ORFV119 with TRAF2, leading to inhibition of NF-κB signaling (Fig 12 and S7 Fig). TRAF2 is
a RING finger protein recruited to TNF receptors to regulate NF-κB signaling both positively
and negatively [60]. Viral proteins that interact with TRAF2 activate or inhibit NF-κB signal-
ing. For example, the MCV protein MC159 was shown to interact with both TRAF2 and
NEMO and to inhibit NF-κB activation [61], while Kaposi’s sarcoma associated-herpes virus
(KSHV) vFLIP and rotavirus VP4 proteins interact with TRAF2 activating NF-κB signaling
[62,63]. The effect of these interactions on TRAF2 function remains unknown. Conceivably,
viral proteins might interfere with NF-κB signaling by modulating TRAF2 E3 ubiquitin ligase
activity and/or by affecting TRAF2 scaffold functions.
ORFV119 is a virion protein (Fig 6) functioning very early in infection ( 30 min) to
inhibit NF-κB signaling. Observed early IKK complex activation on infection of cells with
virus lacking ORFV119 (OV-IA82Δ119) indicates ORFV119 inhibits NF-κB signaling induced
by an early infection event. Early inhibition of IKK complex activation during infection,
ORFV119-TRAF2 interaction in infected cells, and a proposed role for TRAF2 in poxvirus
entry [64] suggest that ORFV119 may be inhibiting ORFV entry mediated activation of NF-κB
signaling. The importance of viral inhibition of NF-κB activation very early in ORFV infection
is further supported by the presence of a second virion-associated NF-κB inhibitor ORFV073
examined by Western blot using anti-TRAF2 or anti-Flag antibodies. (E-H) 293T cells were transfected with
control plasmid (pFlag), pORFV119Flag or pORFV113Flag and harvested at 12 h post transfection. Total cell
lysate and protein extracts immunoprecipitated with anti-Flag (E and G) or anti-TRAF2 (F and H) antibodies
were examined by Western blot using anti-TRAF2 or anti-Flag antibodies. Results are representative of three
independent experiments. Percentage of (A) TRAF2 co-immunoprecipitated by ORFV119Flag in OV-IA82-
RV119Flag infected cells: 35.3±2.7%; (B) ORFV119Flag co-immunoprecipitated by TRAF2 in OV-IA82-
RV119Flag infected cells: 24.7±1.25%; (E) TRAF2 co-immunoprecipitated by ORFV119Flag in pORFV119Flag
transfected cells: 23.7±2.1%; (F) ORFV119Flag co-immunoprecipitated by TRAF2 ORFV119Flag in
pORFV119Flag transfected cells: 18.1±2.02%.
https://doi.org/10.1371/journal.ppat.1006779.g011
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Fig 12. Co-immunoprecipitation of pRb with TRAF2 in 293T cells and ORFV119 with TRAF2 in Saos-2
cells. (A-C) Co-immunoprecipitation of pRb with TRAF2 in 293T cells. 293T cells were transfected with
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(Fig 13). ORFV073 inhibits NF-κB signaling by preventing activation of IKK complex through
interaction with NEMO, the regulatory subunit of the IKK complex [38]. As early infection
events, including those related to cell entry, are likely conserved among poxviruses [65], early
inhibition of NF-κB signaling in poxvirus infected cells may be of greater biological signifi-
cance than currently appreciated.
Notably, at late times post-infection (24 h p.i) ORFV119 also is observed in the nucleus of
infected cells (Fig 2), suggesting that in addition to the early virion-associated NF-κB inhibi-
tory function described here, the protein may perform additional functions in the infected cell.
The fact that most of pRb localizes to the cell nucleus raises the question as to whether
ORFV119 interacts with nuclear pRb at late times post-infection affecting pRb functions such
as transcriptional control and cell cycle regulation.
Other ORFV NF-κB inhibitors have been detected in the nucleus. ORFV002 localized to
the nucleus and inhibited nuclear phosphorylation of NF-κB-p65 by interacting with mitogen
stimulated stress kinase 1 (MSK1) [36,39]. And, ORFV073, a virion-associated NF-κB inhibi-
tor, also was shown to localize to the nucleus yet a nuclear function for the protein has not
been described [38]. Among other poxviruses, vaccinia virus protein K1 localized to the
nucleus where it prevented acetylation of NF-κB-p65 [66].
Examination of published parapoxviral genomes shows that a genomic region encompassing
ORFV119 is affected sporadically by gaps or deletions of as much as 5.7 kbp [67–69]. Notably,
while the extent of the deletion varied considerably, ORFV119 was always affected. The geno-
mic sequence of the PCPV F00-120R strain, for example, was found to contain a 5.5 kbp DNA
deletion that removed genes 116–121 [67]. Retrospective PCR analysis, however, strongly sug-
gested that loss of the 5.5 kbp region occurred during virus passage in tissue culture [68]. Dele-
tions affecting this region were also found in ORFV isolates OV-NP (5.7 kbp deletion) and
OV-SJ1 (1.5 kbp deletion), which were isolated from goat lesion material [69]. Although retro-
spective PCR analysis was not conducted, these virus isolates (cell culture-passage 6) were fully
attenuated following inoculation of goats, further supporting the notion that the genomic loss
occurred during early passage in cells, and indicating that important virulence functions are
encoded within this genomic region. Genomic deletions resulting in complex fragmentation of
the BPSV ORFV119 homolog have also been reported [70]. An explanation for instability of
this genomic region upon virus passage in cell culture is lacking; however, it is possible that loss
of these genes may be advantageous for virus growth in cell culture.
Here, infection with a deletion mutant virus lacking ORFV119 resulted in restricted lesion
development and reduced time to resolution compared with revertant virus infection in the
natural host. The attenuated phenotype of infection likely indicates improved host control of
control plasmid (pFlag) or pORFV119Flag. Total cell lysate and proteins extracts immunoprecipitated with
antibodies against TRAF2 (A), pRb (B) or Flag (C), were examined by Western blot (WB) using anti-pRb, anti-
TRAF2 or anti-Flag antibodies. (D and E) Co-immunoprecipitation of ORFV119 with TRAF2 in Saos-2 cells. Saos-
2 cells were transfected with control plasmid (pFlag) or pORFV119Flag and harvested at 12 h post transfection.
Total cell lysate and protein extracts immunoprecipitated with anti-TRAF2 (D) and anti-Flag (E) antibodies were
examined by Western blot using anti-Flag and anti-TRAF2 antibodies. (F-H) Co-immunoprecipitation of ORFV119
with TRAF2 in Saos-2 cells transiently expressing ORFV119Flag and pRb. Saos-2 cells were co-transfected with
control plasmid (pFlag) or pORFV119Flag and pRb plasmids and harvested at 12 h post transfection. Total cell
lysate and protein extracts immunoprecipitated with anti-TRAF2 (F), anti-Flag (G) and anti-pRb (H) antibodies
were examined by Western blot using anti-Flag, anti-TRAF2 and anti-pRb antibodies. Results are representative
of two independent experiments. Percentage of (A) pRb co-immunoprecipitated by TRAF2 in pFlag transfected
cells: 5.1±0.58%; pORFV119Flag transfected cells: 28.4±2.73%; (B) TRAF2 co-immunoprecipitated by pRb in
pFlag transfected cells: 3.1±0.53%; pORFV119Flag transfected cells: 10.3±1.64%. (F) ORFV119Flag co-immuno-
precipitated by TRAF2 in pORFV119Flag and pRb transfected cells: 15.2±1.26%; (G) TRAF2 co-immunoprecipit-
ated by ORFV119Flag in pORFV119Flag and pRb transfected cells: 18.7±0.96%.
https://doi.org/10.1371/journal.ppat.1006779.g012
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ORFV infection in the absence of ORFV119 (S8 Fig). Our results are at variance with a previ-
ous report where no differences in virulence and pathogenesis were observed between wild
type and ORFV119 deletion viruses [71]. The discrepancy likely reflects differences in viral
strains (IA82 vs SHZ1), extent of genomic deletion, and/or in vitro conditions for virus
propagation.
Overall, ORFV pathogenesis studies in the natural host using viruses lacking single NF-κB
inhibitor genes have shown a remarkable spectrum of phenotypes, ranging from wild type dis-
ease (ORFV002, ORFV024) to moderate (ORFV073, ORFV119), or marked attenuation
(ORFV121) [35–38]. The multiple NF-κB inhibitors encoded by a poxvirus together with the
possibility of overlapping or complementing functions may explain these observations. Alter-
natively, specific poxviral NF-κB inhibitors may exert only subtle and perhaps transient host
range effects on specific infected cells or the infected tissue microenvironment. Regardless, the
impact of these subtle changes on viral fitness in nature may be difficult to fully ascertain
under experimental conditions.
Supporting information
S1 Fig. Growth characteristics of deletion mutant virus OV-IA82-Δ119. OFTu cells were
infected with wild type OV-IA82, deletion mutant OV-IA82-Δ119, or revertant OV-IA82-
RV119Flag viruses (MOI, 10), and titers were determined at 6 h, 12 h, 36 h, and 48 h p.i. and
expressed as TCID50 /ml. Results are mean values from two independent experiments.
(TIF)
Fig 13. Regulation of NF-κB signaling pathway by ORFV virion associated NF-κB inhibitors. ORFV073
inhibits NF-κB signaling by preventing activation of IKK complex through interaction with NEMO, the
regulatory subunit of the IKK complex. ORFV119 interacts with pRb and TRAF2 inhibiting the activity of IKK
complex and downstream NF-κB signaling early in infection. Localization of pRb in virions remains to be
demonstrated.
https://doi.org/10.1371/journal.ppat.1006779.g013
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S2 Fig. Co-immunoprecipitation of ORFV119 with pRb. (A and B) HeLa cells were trans-
fected with control plasmid (pFlag) or pORFV119Flag and harvested at 12h post transfection.
Total cell lysate and proteins extracts immunoprecipitated with antibodies against anti-Flag
(A) or anti-pRb (B), were examined by Western blot (WB) using anti-pRb or anti-Flag anti-
bodies. Results are representative of two independent experiments. Percentage of pRb co-
immunoprecipitated by ORFV119Flag: 21.5±2.34%; Percentage of ORFV119Flag co-immuno-
precipitated by pRb: 38.7±2.61%.
(TIF)
S3 Fig. Effect of ORFV119 on NF-κB-p65 activation during ORFV infection. (A) OFTu
cells infected with OV-IA82 or OV-IA82-Δ119 (MOI, 10) were harvested at indicated times p.
i. Total cell protein extracts (50 μg) were resolved by SDS-PAGE, blotted and probed with anti-
bodies against total or Phospho (Ser536) NF-κB-p65. (B) Densitometry of Phospho NF-κB-
p65 bands were normalized to the total NF-κB-p65 bands. Fold changes are shown relative to
OV-IA82 treatment and results are mean values of two independent experiments (P< 0.05).
(TIF)
S4 Fig. Effect of ORFV119 on E2F-mediated luciferase activity in ORFV infected cells. OFTu
cells were co-transfected with a pE2F-Luc and pRL-TK plasmids. At 24 h post transfection cells
were mock infected or infected with OV-IA82, OV-IA82Δ119, or OV-IA82-RV119LxGxE-Flag.
Firefly and sea pansy luciferase activities were measured at 1, 2, 4 and 6 h p.i. and expressed as
relative fold changes in luciferase activity compared to mock treatment (P<0.05;  P<0.01).
Results are mean values of three independent experiments. No significant difference was
observed between the viruses.
(TIF)
S5 Fig. Effect of ORFV119 on poly(I:C), poly(A:T) or ORFV DNA induced NF-κB-medi-
ated luciferase activity in HeLa cells. HeLa cells were co-transfected with pNF-κB-Luc,
pRL-TK and pFlag or pORFV119Flag. At 24 h after transfection, cells were induced with poly(I:
C) (500 ng), poly(A:T) (750 ng) or ORFV DNA (1 μg). Cells were harvested at 20 h p.i., and
firefly and sea pansy luciferase activities were measured and expressed as fold changes in lucif-
erase activity compared to uninduced (UN) cells (P<0.05). Results are mean values of two
independent experiments.
(TIF)
S6 Fig. Effect of OV-IA82-RV119LxGxE-Flag or OV-IA82-RV119LxGxE-Flag-Rb- virus in NF-
κB-p65 nuclear translocation in OFTu or OFTuRb- cells. (A) OFTu or OFTuRb- cells were
infected with OV-IA82-RV119LxGxE-Flag (LxGxE virus) or OV-IA82-RV119LxGxE-Flag-Rb-
(LxGxERb- virus) as described in Materials and Methods and cells were fixed at 1 h p.i. sequen-
tially probed with antibody against NF-κB-p65 and Alexa Fluor 594 labeled secondary anti-
body, counterstained with DAPI, and examined by confocal microscopy. Red, NF-κB-p65;
Blue, DAPI. (B) Cells were counted (n = 500 cells/slide) and results are shown as percentage of
cells expressing nuclear NF-κB-p65. Results are mean values from two independent experi-
ments. p values for LxGxE virus/OFTu cells vs LxGxE virus/OFTuRb- cells, LxGxERb- virus/
OFTu cells and LxGxERb- virus/OFTuRb- cells were not significant (P>0.05).
(TIF)
S7 Fig. Co-immunoprecipitation of ORFV119LxGxE with TRAF2. (A and B) 293T cells were
transfected with control plasmid (pFlag) or pORFV119LxGxE-Flag (p119LxGxE-Flag) and harvested
at 12h post transfection. Total cell lysate and proteins extracts immunoprecipitated with anti-
bodies against anti-Flag (A) or anti-TRAF2 (B), were examined by Western blot (WB) using
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anti-TRAF2 or anti-Flag antibodies. Results are representative of two independent experi-
ments.
(TIF)
S8 Fig. Effect of ORFV119 on ORFV virulence in the natural host. Sheep were topically inoc-
ulated with OV-IA82-Δ119 (sheep # 39, 43, 513, and 622), OV-IA82-RV119Flag (sheep # 19, 79,
101 and 639) (0.5 ml, 107 TCID50/ml) or PBS (3 animals) on the scarified skin of the right lower
lip. (A). Clinical course of disease for OV-IA82-Δ119 (Δ119) and OV-IA82-RV119Flag (RV119).




We thank Bahaa A. Fadlalla (University of Illinois) for his advice and technical assistance, Fer-
nando A. Osorio (Nebraska Center for Virology, University of Nebraska- Lincoln) for labora-
tory support, UNL animal facility staff for technical support and Timothy M. Fan (Department
of Veterinary Clinical Medicine at the University of Illinois at Urbana-Champaign) for provid-
ing Saos-2 cells used in this study.
Author Contributions
Conceptualization: Ponnuraj Nagendraprabhu, Sushil Khatiwada, Sabal Chaulagain, Gustavo
Delhon, Daniel L. Rock.
Formal analysis: Ponnuraj Nagendraprabhu, Sushil Khatiwada, Gustavo Delhon, Daniel L.
Rock.
Funding acquisition: Daniel L. Rock.
Investigation: Ponnuraj Nagendraprabhu, Sushil Khatiwada, Sabal Chaulagain, Gustavo Del-
hon, Daniel L. Rock.
Methodology: Ponnuraj Nagendraprabhu, Sushil Khatiwada, Gustavo Delhon, Daniel L.
Rock.
Supervision: Gustavo Delhon, Daniel L. Rock.
Writing – original draft: Ponnuraj Nagendraprabhu, Sushil Khatiwada, Gustavo Delhon,
Daniel L. Rock.
Writing – review & editing: Ponnuraj Nagendraprabhu, Sushil Khatiwada, Gustavo Delhon,
Daniel L. Rock.
References
1. Fleming SB, Wise LM, Mercer AA. Molecular genetic analysis of orf virus: A poxvirus that has adapted
to skin. Viruses. 2015; 7: 1505–1539. https://doi.org/10.3390/v7031505 PMID: 25807056
2. Haig DM, Mercer AA. Ovine diseases. Orf. Vet. Res. 1998; 29: 311–326. PMID: 9689744
3. Erickson GA, Carbrey EA, Gustafson GA. Generalized contagious ecthyma in a sheep rancher: diag-
nostic considerations. J Am Vet Med Assoc. 1975; 166: 262–263. PMID: 1094013
4. Meechan JG, MacLeod RI. Human labial orf: a case report. Br Dent J. 1992; 173: 343–344. PMID:
1467011
5. Sanchez RL, Hebert A, Lucia H, Swedo J. Orf. A case report with histologic, electron microscopic, and
immunoperoxidase studies. Arch Pathol Lab Med. 1985; 109: 166–170. PMID: 3883947
ORFV119 inhibits NF-κB signaling
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006779 December 15, 2017 32 / 36
6. McKeever DJ, Jenkinson DM, Hutchison G, Reid HW. Studies of the pathogenesis of orf virus infection
in sheep. J Comp Pathol. 1988; 99: 317–328. PMID: 3204166
7. Kalali BN, Ko¨llisch G, Mages J, Mu¨ller T, Bauer S, Wagner H, Ring J, Lang R, Mempel M, Ollert M. Dou-
ble-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-,
and MDA5/RIG-I-mediated differential signaling. J Immunol. 2008; 181: 2694–2704. PMID: 18684960
8. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Nickoloff Skin immune sentinels in health and disease.
Nat Rev Immunol. 2009; 9: 679–691. https://doi.org/10.1038/nri2622 PMID: 19763149
9. Kaufman CK, Fuchs E. It’s got you covered: NF-kappaB in the epidermis. J Cell Biol. 2000; 149: 999–
1004. PMID: 10831603
10. Vallabhapurapu S, Karin M. Regulation and function of NFkappaB transcription factors in the immune
system. Annu. Rev. Immunol. 2009; 27: 693–733. https://doi.org/10.1146/annurev.immunol.021908.
132641 PMID: 19302050
11. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Onco-
gene. 2006; 25: 6685–6705. https://doi.org/10.1038/sj.onc.1209934 PMID: 17072322
12. Chen L-F, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol. 2004; 5: 392–
401. https://doi.org/10.1038/nrm1368 PMID: 15122352
13. Amaya M, Keck F, Bailey C, Narayanan A. The role of the IKK complex in viral infections. Pathog Dis.
2014; 72: 32–44. https://doi.org/10.1111/2049-632X.12210 PMID: 25082354
14. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008; 132: 344–362. https://doi.
org/10.1016/j.cell.2008.01.020 PMID: 18267068
15. Chen ZJ. Ubiquitin signaling in the NF-kappaB pathway. Nat Cell Biol. 2005; 7: 758–765. https://doi.org/
10.1038/ncb0805-758 PMID: 16056267
16. Adhikari A, Xu M, Chen ZJ. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene. 2007; 26: 3214–
3226. https://doi.org/10.1038/sj.onc.1210413 PMID: 17496917
17. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of
MKK and IKK. Nature. 2001; 412: 346–351. https://doi.org/10.1038/35085597 PMID: 11460167
18. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ. Activation of the
IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a
unique polyubiquitin chain. Cell. 2000; 103: 351–361. PMID: 11057907
19. Brady G, Bowie AG. Innate immune activation of NFkappaB and its antagonism by poxviruses. Cyto-
kine Growth Factor Rev. 2014; 25: 611–620. https://doi.org/10.1016/j.cytogfr.2014.07.004 PMID:
25081317
20. Smith GL, Benfield CT, Maluquer de Motes C, Mazzon M, Ember SW, Ferguson BJ, Sumner RP. Vac-
cinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol. 2013; 94: 2367–
2392. https://doi.org/10.1099/vir.0.055921-0 PMID: 23999164
21. Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, O’Neill LA. A46R and A52R from vaccinia
virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A. 2000; 97:
10162–10167. https://doi.org/10.1073/pnas.160027697 PMID: 10920188
22. Chen RA-J, Ryzhakov G, Cooray S, Randow F, Smith GL. Inhibition of IkappaB kinase by vaccinia virus
virulence factor B14. PLoS Pathog. 2008; 4: e22. https://doi.org/10.1371/journal.ppat.0040022 PMID:
18266467
23. Ember SWJ, Ren H, Ferguson BJ, Smith GL. Vaccinia virus protein C4 inhibits NF-κB activation and
promotes virus virulence. J Gen Virol. 2012; 93: 2098–2108. https://doi.org/10.1099/vir.0.045070-0
PMID: 22791606
24. DiPerna G, Stack J, Bowie AG, Boyd A, Kotwal G, Zhang Z, Arvikar S, Latz E, Fitzgerald KA, Marshall
WL. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the
tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like
receptors. J Biol Chem. 2004; 279: 36570–36578. https://doi.org/10.1074/jbc.M400567200 PMID:
15215253
25. Gedey R, Jin X-L, Hinthong O, Shisler JL. Poxviral regulation of the host NF-kappaB response: the vac-
cinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected
human embryonic kidney cells. J Virol. 2006; 80: 8676–8685. https://doi.org/10.1128/JVI.00935-06
PMID: 16912315
26. Shisler JL, Jin X-L. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by prevent-
ing IkappaBalpha degradation. J Virol. 2004; 78: 3553–3560. https://doi.org/10.1128/JVI.78.7.3553-
3560.2004 PMID: 15016878
27. Mansur DS, Maluquer de Motes C, Unterholzner L, Sumner RP, Ferguson BJ, Ren H, Strnadova P,
Bowie AG, Smith GL. Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to
ORFV119 inhibits NF-κB signaling
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006779 December 15, 2017 33 / 36
inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog. 2013; 9: e1003183.
https://doi.org/10.1371/journal.ppat.1003183 PMID: 23468625
28. Myskiw C, Arsenio J, van Bruggen R, Deschambault Y, Cao J. Vaccinia virus E3 suppresses expression
of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways. J Virol. 2009; 83:
6757–6768. https://doi.org/10.1128/JVI.02570-08 PMID: 19369349
29. Schro¨der M, Baran M, Bowie AG. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsi-
lon-mediated IRF activation. EMBO J. 2008; 27: 2147–2157. https://doi.org/10.1038/emboj.2008.143
PMID: 18636090
30. Bartlett N, Symons JA, Tscharke DC, Smith GL. The vaccinia virus N1L protein is an intracellular homo-
dimer that promotes virulence. J Gen Virol. 2002; 83: 1965–1976. https://doi.org/10.1099/0022-1317-
83-8-1965 PMID: 12124460
31. Camus-Bouclainville C, Fiette L, Bouchiha S, Pignolet B, Counor D, Filipe C, Gelfi J, Messud-Petit F. A
virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflam-
mation. J Virol. 2004; 78: 2510–2516. https://doi.org/10.1128/JVI.78.5.2510-2516.2004 PMID:
14963153
32. Chen RA, Jacobs N, Smith GL. Vaccinia virus strain Western Reserve protein B14 is an intracellular vir-
ulence factor. J Gen Virol. 2006; 87: 1451–1458. https://doi.org/10.1099/vir.0.81736-0 PMID:
16690909
33. Harte MT, Haga IR, Maloney G, Gray P, Reading PC, Bartlett NW, Smith GL, Bowie A, O’Neill LA. The
poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp
Med. 2003; 197: 343–351. https://doi.org/10.1084/jem.20021652 PMID: 12566418
34. Mohamed MR, Rahman MM, Rice A, Moyer RW, Werden SJ, McFadden G. Cowpox virus expresses a
novel ankyrin repeat NFkappaB inhibitor that controls inflammatory cell influx into virus-infected tissues
and is critical for virus pathogenesis. J Virol. 2009; 83: 9223–9236. https://doi.org/10.1128/JVI.00861-
09 PMID: 19570875
35. Diel DG, Delhon G, Luo S, Flores EF, Rock DL. A novel inhibitor of the NF- {kappa}B signaling pathway
encoded by the parapoxvirus orf virus. J Virol. 2010; 84: 3962–3973. https://doi.org/10.1128/JVI.02291-
09 PMID: 20147406
36. Diel DG, Luo S, Delhon G, Peng Y, Flores EF, Rock DL. A nuclear inhibitor of NF-kappaB encoded by a
poxvirus. J Virol. 2011; 85: 264–275. https://doi.org/10.1128/JVI.01149-10 PMID: 20980501
37. Diel DG, Luo S, Delhon G, Peng Y, Flores EF, Rock DL. Orf virus ORFV121 encodes a novel inhibitor
of NF-kappaB that contributes to virus virulence. J Virol. 2011; 85: 2037–2049. https://doi.org/10.1128/
JVI.02236-10 PMID: 21177808
38. Khatiwada S, Delhon G, Nagendraprabhu P, Chaulagain S, Luo S, Diel DG, Flores EF, Rock DL. A
parapoxviral virion protein inhibits NF-κB signaling early in infection. PLoS Pathog. 2017; 13:
e1006561. https://doi.org/10.1371/journal.ppat.1006561 PMID: 28787456
39. Ning Z, Zheng Z, Hao W, Duan C, Li W, Wang Y, Li M, Luo S. The N terminus of orf virus-encoded pro-
tein 002 inhibits acetylation of NF-κB p65 by preventing Ser(276) phosphorylation. PLoS One. 2013; 8:
e58854. https://doi.org/10.1371/journal.pone.0058854 PMID: 23536830
40. Dick FA, Rubin SM. Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol.
2013; 14: 297–306. https://doi.org/10.1038/nrm3567 PMID: 23594950
41. Ferrari R, Gou D, Jawdekar G, Johnson SA, Nava M, Su T, Yousef AF, Zemke NR, Pellegrini M, Kurdis-
tani SK, Berk AJ. Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Sup-
pressor Rb to Repress Select Host Genes and Promote Productive Virus Infection. Cell Host Microbe.
2014; 16: 663–676. https://doi.org/10.1016/j.chom.2014.10.004 PMID: 25525796
42. Kalejta RF, Bechtel JT, Shenk T. Human cytomegalovirus pp71 stimulates cell cycle progression by
inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors.
Mol Cell Biol. 2003; 23: 1885–1895. https://doi.org/10.1128/MCB.23.6.1885-1895.2003 PMID:
12612064
43. Gonzalez SL, Stremlau M, He X, Basile JR, Munger K. Degradation of the retinoblastoma tumor sup-
pressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and
is separable from proteasomal degradation of E7. J Virol. 2001; 75: 7583–7591. https://doi.org/10.1128/
JVI.75.16.7583-7591.2001 PMID: 11462030
44. Cook JL, Walker TA, Worthen GS, Radke JR. Role of the E1A Rb-binding domain in repression of the
NF-kappa B-dependent defense against tumor necrosis factor-alpha. Proc Natl Acad Sci U S A. 2002;
99: 9966–9971. https://doi.org/10.1073/pnas.162082999 PMID: 12119420
45. Garcia MA, Gallego P, Campagna M, Gonza´lez-Santamarı´a J, Martı´nez G, Marcos-Villar L, Vidal A,
Esteban M, Rivas C. Activation of NF-κB Pathway by Virus Infection Requires Rb Expression. PLoS
One. 2009; 4: e6422. https://doi.org/10.1371/journal.pone.0006422 PMID: 19649275
ORFV119 inhibits NF-κB signaling
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006779 December 15, 2017 34 / 36
46. Singh M, Krajewski M, Mikolajka A, Holak TA. Molecular Determinants for the Complex Formation
between the Retinoblastoma Protein and LXCXE Sequences. J Biol Chem. 2005; 280: 37868–378676.
https://doi.org/10.1074/jbc.M504877200 PMID: 16118215
47. Delhon G, Tulman ER, Afonso CL, Lu Z, de la Concha-Bermejillo A, Lehmkuhl HD, Piccone ME, Kutish
GF, Rock DL. Genomes of the parapoxviruses ORF virus and bovine papular stomatitis virus. J Virol.
2004; 78: 168–177. https://doi.org/10.1128/JVI.78.1.168-177.2004 PMID: 14671098
48. Krauss O, Hollinshead R, Hollinshead M, Smith GL. An investigation of incorporation of cellular antigens
into vaccinia virus particles. J Gen Virol. 2002; 83: 2347–2359. https://doi.org/10.1099/0022-1317-83-
10-2347 PMID: 12237415
49. Wang X, Zhang J, Hao W, Peng Y, Li H, Li W, Li M, Luo S. Isolation and Characterization of Monoclonal
Antibodies Against a Virion Core Protein of Orf Virus Strain NA1/11 As Potential Diagnostic Tool for Orf
Viruses. Monoclon Antib Immunodiagn Immunother. 2015; 34: 233–245. https://doi.org/10.1089/mab.
2014.0101 PMID: 26301926
50. Li M, Zhang Z, Koh H, Lu R, Jiang Z, Alioua A, Garcia-Valdes J, Stefani E, Toro L. The β1-subunit of the
MaxiK channel associates with the thromboxane A2 receptor and reduces thromboxane A2 functional
effects. J Biol Chem. 2013; 288: 3668–3677. https://doi.org/10.1074/jbc.M112.426585 PMID:
23255603
51. Friederichs S, Krebs S, Blum H, Lang H, Bu¨ttner M. Parapoxvirus (PPV) of red deer reveals subclinical
infection and confirms a unique species. J Gen Virol. 2015; 96: 1446–1462. https://doi.org/10.1099/vir.
0.000080 PMID: 25701822
52. Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol. 2000; 2: E65–
E67. https://doi.org/10.1038/35008695 PMID: 10783254
53. Balassu TC, Robinson AJ. Orf virus replication in bovine testis cells: kinetics of viral DNA, polypeptide,
and infectious virus production and analysis of virion polypeptides. Arch Virol. 1987; 97: 267–281.
PMID: 3426396
54. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA. Physical Interaction of the Retinoblas-
toma Protein with Human D Cyclins. Cell. 1993; 73: 499–511. PMID: 8490963
55. Shew JY, Lin BT, Chen PL, Tseng BY, Yang-Feng TL, Lee WH. C-terminal truncation of the retinoblas-
toma gene product leads to functional inactivation. Proc Natl Acad Sci U S A.1990; 87: 6–10. PMID:
1688660
56. Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell
Biol. 2009; 10: 207–217. https://doi.org/10.1038/nrm2636 PMID: 19209183
57. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signaling: implications for inflammatory
diseases. Nat Rev Immunol. 2009; 9: 778–788. https://doi.org/10.1038/nri2655 PMID: 19855404
58. Wullaert A, Bonnet MC, Pasparakis M. NF-κB in the regulation of epithelial homeostasis and inflamma-
tion. Cell Res. 2011; 21: 146–158. https://doi.org/10.1038/cr.2010.175 PMID: 21151201
59. Mohr S, Grandemange S, Massimi P, Darai G, Banks L, Martinou JC, Zeier M, Muranyi W. Targeting
the Retinoblastoma Protein by MC007L, Gene Product of the Molluscum Contagiosum Virus: Detection
of a Novel Virus-Cell Interaction by a Member of the Poxviruses. J Virol. 2008; 82: 10625–10633.
https://doi.org/10.1128/JVI.01187-08 PMID: 18701596
60. Borghi A, Verstrepen L, Beyaert R. TRAF2 multitasking in TNF receptor-induced signaling to NF-κB,
MAP kinases and cell death. Biochem Pharmacol. 2016; 116: 1–10. https://doi.org/10.1016/j.bcp.2016.
03.009 PMID: 26993379
61. Randall CM, Jokela JA, Shisler JL. The MC159 protein from the molluscum contagiosum poxvirus inhib-
its NF-κB activation by interacting with the IκB kinase complex. J Immunol. 2012; 188: 2371–2379.
https://doi.org/10.4049/jimmunol.1100136 PMID: 22301546
62. Guasparri I, Wu H, Cesarman E. The KSHV oncoprotein vFLIPcontains a TRAF-interacting motif and
requires TRAF2 and TRAF3 for signaling. EMBO rep. 2006; 7: 114–119. https://doi.org/10.1038/sj.
embor.7400580 PMID: 16311516
63. LaMonica R, Kocer SS, Nazarova J, Dowling W, Geimonen E, Shaw RD, Mackow ER. VP4 differentially
regulates TRAF2 signaling, disengaging JNK activation while directing NF-κB to effect rotavirus-specific
cellular responses. J Biol Chem. 2001; 276: 19889–19896. https://doi.org/10.1074/jbc.M100499200
PMID: 11262403
64. Haga IR, Jowers TP, Griffiths SJ, Haas J, Beard PM. TRAF2 facilitates vaccinia virus replication by pro-
moting rapid virus entry. J Virol. 2014; 88: 3664–3677. https://doi.org/10.1128/JVI.03013-13 PMID:
24429366
65. Laliberte JP, Weisberg AS, Moss B. The membrane fusion step of vaccinia virus entry is cooperatively
mediated by multiple viral proteins and host cell components. PLoS Pathog. 2011; 7: e1002446. https://
doi.org/10.1371/journal.ppat.1002446 PMID: 22194690
ORFV119 inhibits NF-κB signaling
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006779 December 15, 2017 35 / 36
66. Bravo Cruz AG, Shisler JL. Vaccinia virus K1 ankyrin repeat protein inhibits NF-κB activation by pre-
venting RelA acetylation. J Gen Virol. 2016; 97: 2691–2702. https://doi.org/10.1099/jgv.0.000576
PMID: 27503790
67. Hautaniemi M, Ueda N, Tuimala J, Mercer AA, Lahdenpera¨ J, McInnes CJ. The genome of pseudocow-
poxvirus: comparison of a reindeer isolate and a reference strain. J Gen Virol. 2010; 91: 1560–1576.
https://doi.org/10.1099/vir.0.018374-0 PMID: 20107016
68. Hautaniemi M, Vaccari F, Scacliarini A, Laaksonen S, Huovilainen A, McInnes CJ. Analysis of deletion
within the reindeer pseudocowpoxvirus genome. Virus Res. 2011; 160: 326–332. https://doi.org/10.
1016/j.virusres.2011.07.005 PMID: 21798294
69. Chi X, Zeng X, Li W, Hao W, Li M, Huang X, Huang Y, Rock DL, Luo S, Wang S. Genome analysis of orf
virus isolates from goats in the Fujian Province of southern China. Front Microbiol. 2015; 6: 1135.
https://doi.org/10.3389/fmicb.2015.01135 PMID: 26557108
70. Huang T, Tulman ER, Diel DG, Khatiwada S, Sims W, Edwards JF, Wen X, Kutish GF, Rock DL, Delhon
G. Coinfection with multiple strains of Bovine Papular Stomatitis Virus. Arch Virol. 2015; 160: 1527–
1532. https://doi.org/10.1007/s00705-015-2394-2 PMID: 25804193
71. Qiao J, Yang HB, Peng YL, Meng QL, Chen C, Ma Y, Xie K, Liu TL, Cai XP, Chen CF. Effect of ORF119
gene deletion on the replication and virulence of orf virus. Acta Virologica. 2015; 59: 257–264. PMID:
26435149
ORFV119 inhibits NF-κB signaling
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006779 December 15, 2017 36 / 36
